In	O
vivo	O
detection	O
of	O
intracellular	O
signaling	O
pathways	O
in	O
developing	O
thymocytes	B-cell_type
.	O

Information	O
regarding	O
the	O
intracellular	O
signaling	O
processes	O
that	O
occur	O
during	O
the	O
development	O
of	O
T	B-cell_type
cells	I-cell_type
has	O
largely	O
been	O
obtained	O
with	O
the	O
use	O
of	O
transgenic	O
mouse	O
models	O
,	O
which	O
although	O
providing	O
invaluable	O
information	O
are	O
time	O
consuming	O
and	O
costly	O
.	O

To	O
this	O
end	O
,	O
we	O
have	O
developed	O
a	O
novel	O
system	O
that	O
facilitates	O
the	O
in	O
vivo	O
analysis	O
of	O
signal	O
transduction	O
pathways	O
during	O
T-lymphocyte	B-cell_type
development	O
.	O

This	O
approach	O
uses	O
reporter-plasmids	B-DNA
for	O
the	O
detection	O
of	O
intracellular	O
signals	O
mediated	O
by	O
the	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
or	O
cyclic	B-protein
AMP-dependent	I-protein
protein	I-protein
kinase	I-protein
.	O

Reporter-plasmids	B-DNA
are	O
transfected	O
into	O
thymocytes	B-cell_type
in	O
fetal	O
thymic	O
organ	O
culture	O
by	O
accelerated	O
DNA/particle	O
bombardment	O
(	O
gene	O
gun	O
)	O
,	O
and	O
the	O
activation	O
of	O
a	O
signaling	O
pathway	O
is	O
determined	O
in	O
the	O
form	O
of	O
a	O
standard	O
luciferase	O
assay	O
.	O

Importantly	O
,	O
this	O
powerful	O
technique	O
preserves	O
the	O
structural	O
integrity	O
of	O
the	O
thymus	O
,	O
and	O
will	O
provide	O
an	O
invaluable	O
tool	O
to	O
study	O
how	O
thymocytes	B-cell_type
respond	O
to	O
normal	O
environmental	O
stimuli	O
encountered	O
during	O
differentiation	O
within	O
the	O
thymic	O
milieu	O
.	O

Thus	O
,	O
this	O
method	O
allows	O
for	O
the	O
monitoring	O
of	O
signals	O
that	O
occur	O
in	O
a	O
biological	O
time	O
frame	O
,	O
such	O
as	O
during	O
differentiation	O
,	O
and	O
within	O
the	O
natural	O
environment	O
of	O
differentiating	B-cell_type
cells	I-cell_type
.	O

Developmental	NULL
Immunology	NULL
,	NULL
2000	NULL
,	NULL
Vol	NULL
.	NULL

8	NULL
(	NULL
1	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

31-45	NULL
Reprints	NULL
available	NULL
directly	NULL
from	NULL
the	NULL
publisher	NULL
Photocopying	NULL
permitted	NULL
by	NULL
license	NULL
only	NULL
©	NULL
2000	NULL
OPA	NULL
(	NULL
Overseas	NULL
Publishers	NULL
Association	NULL
)	NULL
N.V	NULL
.	NULL

Published	NULL
by	NULL
license	NULL
under	NULL
the	NULL
Harwood	NULL
Academic	NULL
Publishers	NULL
imprint	NULL
,	NULL
part	NULL
of	NULL
The	NULL
Gordon	NULL
and	NULL
Breach	NULL
Publishing	NULL
Group	NULL
.	NULL

in	NULL
Developing	NULL
Thymocytes	NULL
ALISON	NULL
M.	NULL
MICHIE	NULL
``	NULL
and	NULL
JUAN	NULL
CARLOS	NULL
ZUNIGA-PFLUCKER	NULL
(	NULL
Received	NULL
October	NULL
29	NULL
,	NULL
1999	NULL
)	NULL
Information	NULL
regarding	NULL
the	NULL
intracellular	NULL
signaling	NULL
processes	NULL
that	NULL
occur	NULL
during	NULL
the	NULL
development	NULL
of	NULL
T	NULL
cells	NULL
has	NULL
largely	NULL
been	NULL
obtained	NULL
with	NULL
the	NULL
use	NULL
of	NULL
transgenic	NULL
mouse	NULL
models	NULL
,	NULL
which	NULL
although	NULL
providing	NULL
invaluable	NULL
information	NULL
are	NULL
time	NULL
consuming	NULL
and	NULL
costly	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
have	NULL
developed	NULL
a	NULL
novel	NULL
system	NULL
that	NULL
facilitates	NULL
the	NULL
in	NULL
vivo	NULL
analysis	NULL
of	NULL
signal	NULL
transduction	NULL
pathways	NULL
during	NULL
T-lymphocyte	NULL
development	NULL
.	NULL

This	NULL
approach	NULL
uses	NULL
reporter-plasmids	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
intracellular	NULL
signals	NULL
mediated	NULL
by	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
or	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
.	NULL

Reporter-plasmids	NULL
are	NULL
transfected	NULL
into	NULL
thymocytes	NULL
in	NULL
fetal	NULL
thymic	NULL
organ	NULL
culture	NULL
by	NULL
accelerated	NULL
DNA/particle	NULL
bombardment	NULL
(	NULL
gene	NULL
gun	NULL
)	NULL
,	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
signaling	NULL
pathway	NULL
is	NULL
determined	NULL
in	NULL
the	NULL
form	NULL
of	NULL
a	NULL
standard	NULL
luciferase	NULL
assay	NULL
.	NULL

Importantly	NULL
,	NULL
this	NULL
powerful	NULL
technique	NULL
preserves	NULL
the	NULL
structural	NULL
integrity	NULL
of	NULL
the	NULL
thymus	NULL
,	NULL
and	NULL
will	NULL
provide	NULL
an	NULL
invaluable	NULL
tool	NULL
to	NULL
study	NULL
how	NULL
thymocytes	NULL
respond	NULL
to	NULL
normal	NULL
environmental	NULL
stimuli	NULL
encountered	NULL
during	NULL
differentiation	NULL
within	NULL
the	NULL
thymic	NULL
milieu	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
method	NULL
allows	NULL
for	NULL
the	NULL
monitoring	NULL
of	NULL
signals	NULL
that	NULL
occur	NULL
in	NULL
a	NULL
biological	NULL
time	NULL
frame	NULL
,	NULL
such	NULL
as	NULL
during	NULL
differentiation	NULL
,	NULL
and	NULL
within	NULL
the	NULL
natural	NULL
environment	NULL
of	NULL
differentiating	NULL
cells	NULL
.	NULL

Keywords	NULL
:	NULL
Cellular	NULL
signaling	NULL
,	NULL
FTOC	NULL
,	NULL
T-cell	NULL
development	NULL
,	NULL
thymus	NULL
,	NULL
transfection	NULL
Abbreviations	NULL
:	NULL
cyclic	NULL
AMP	NULL
,	NULL
cyclic	NULL
adenosine	NULL
monophosphate	NULL
,	NULL
CREB	NULL
,	NULL
cyclic	NULL
AMP	NULL
response	NULL
,	NULL
element	NULL
binding	NULL
protein	NULL
,	NULL
CMV	NULL
,	NULL
cytomegalovirus	NULL
,	NULL
FTOC	NULL
,	NULL
fetal	NULL
thymic	NULL
organ	NULL
culture	NULL
,	NULL
DN	NULL
,	NULL
CD4	NULL
``	NULL
CD8	NULL
double	NULL
negative	NULL
thymocytes	NULL
,	NULL
DP	NULL
,	NULL
CD4*	NULL
CD8+*	NULL
double	NULL
positive	NULL
thymocytes	NULL
,	NULL
MAPK	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
,	NULL
PKA	NULL
,	NULL
cyclic	NULL
AMP	NULL
dependent	NULL
protein	NULL
kinase	NULL
,	NULL
PMA	NULL
,	NULL
phorbol-12-myristate-13-acetate	NULL
,	NULL
SCF	NULL
,	NULL
stem	NULL
cell	NULL
factor	NULL
,	NULL
TCR	NULL
,	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
Printed	NULL
in	NULL
Malaysia	NULL
In	NULL
Vivo	NULL
Detection	NULL
of	NULL
Intracellular	NULL
Signaling	NULL
Pathways	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
1	NULL
King	NULL
's	NULL
College	NULL
Circle	NULL
,	NULL
University	NULL
of	NULL
Toronto	NULL
,	NULL
Toronto	NULL
,	NULL
Ontario	NULL
M5S	NULL
1A8	NULL
,	NULL
Canada	NULL
INTRODUCTION	NULL
Thymocyte	NULL
development	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
stage-specific	NULL
expression	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
surface	NULL
molecules	NULL
(	NULL
Godfrey	NULL
and	NULL
Zlotnik	NULL
,	NULL
1993	NULL
;	NULL
Shortman	NULL
and	NULL
Wu	NULL
,	NULL
1996	NULL
;	NULL
Zufiiga-Pfliicker	NULL
and	NULL
Lenardo	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
earliest	NULL
thymic	NULL
immigrants	NULL
,	NULL
arriving	NULL
from	NULL
the	NULL
fetal	NULL
liver	NULL
or	NULL
bone	NULL
marrow	NULL
,	NULL
lack	NULL
CD4	NULL
and	NULL
CD8	NULL
expression	NULL
(	NULL
CD4	NULL
CD8	NULL
,	NULL
double	NULL
negative	NULL
(	NULL
DN	NULL
)	NULL
)	NULL
(	NULL
Godfrey	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Only	NULL
thymocytes	NULL
that	NULL
successfully	NULL
rearrange	NULL
their	NULL
TCR-B	NULL
locus	NULL
expand	NULL
and	NULL
differentiate	NULL
to	NULL
the	NULL
CD4*	NULL
CD8*	NULL
(	NULL
double	NULL
positive	NULL
,	NULL
DP	NULL
)	NULL
stage	NULL
;	NULL
a	NULL
checkpoint	NULL
known	NULL
as	NULL
B-selection	NULL
(	NULL
Hoffman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
von	NULL
Boehmer	NULL
and	NULL
Fehling	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Following	NULL
B-selection	NULL
,	NULL
the	NULL
initiation	NULL
of	NULL
TCR-	NULL
«	NULL
gene	NULL
expression	NULL
and	NULL
rearrangement	NULL
occurs	NULL
(	NULL
von	NULL
Boehmer	NULL
and	NULL
Fehling	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

DP	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
416-978-8217	NULL
,	NULL
Fax	NULL
:	NULL
416-978-1938	NULL
,	NULL
E-mail	NULL
:	NULL
alison.michie	NULL
@	NULL
utoronto.ca	NULL
.	NULL

31	NULL
32	NULL
ALISON	NULL
M.	NULL
MICHIE	NULL
and	NULL
JUAN	NULL
CARLOS	NULL
ZUNIGA-PFLUCKER	NULL
thymocytes	NULL
expressing	NULL
a	NULL
complete	NULL
afB-TCR/CD3	NULL
complex	NULL
undergo	NULL
further	NULL
checkpoints	NULL
,	NULL
positive	NULL
and	NULL
negative	NULL
selection	NULL
(	NULL
Fowlkes	NULL
and	NULL
Schweighoffer	NULL
,	NULL
1995	NULL
;	NULL
Kisielow	NULL
and	NULL
von	NULL
Boehmer	NULL
,	NULL
1990	NULL
)	NULL
,	NULL
which	NULL
result	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
CD4*	NULL
CD8	NULL
and	NULL
CD4	NULL
CD8t	NULL
mature	NULL
thymocytes	NULL
.	NULL

The	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
that	NULL
surround	NULL
these	NULL
checkpoints	NULL
and	NULL
drive	NULL
the	NULL
maturation	NULL
process	NULL
of	NULL
thymocytes	NULL
are	NULL
-	NULL
not	NULL
well-defined	NULL
.	NULL

Transgenic	NULL
mouse	NULL
models	NULL
have	NULL
enabled	NULL
the	NULL
identification	NULL
of	NULL
key	NULL
signaling	NULL
components	NULL
necessary	NULL
during	NULL
T-cell	NULL
development	NULL
,	NULL
such	NULL
as	NULL
Ras	NULL
,	NULL
Rho	NULL
GTPase	NULL
,	NULL
Lock	NULL
,	NULL
SLP-76	NULL
,	NULL
LAT	NULL
,	NULL
ZAP-70	NULL
(	NULL
Clements	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Galandrini	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Levin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Molina	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Negishi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Swan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Swat	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
studies	NULL
are	NULL
informative	NULL
,	NULL
they	NULL
fail	NULL
to	NULL
provide	NULL
a	NULL
biological	NULL
time	NULL
frame	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
proximal	NULL
and	NULL
distal	NULL
signaling	NULL
pathways	NULL
that	NULL
occur	NULL
at	NULL
checkpoints	NULL
during	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

To	NULL
study	NULL
the	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
or	NULL
cellular	NULL
signaling	NULL
events	NULL
during	NULL
thymocyte	NULL
development	NULL
several	NULL
experimental	NULL
strategies	NULL
are	NULL
available	NULL
.	NULL

These	NULL
approaches	NULL
rely	NULL
on	NULL
the	NULL
introduction	NULL
of	NULL
foreign	NULL
DNA	NULL
into	NULL
thymocytes	NULL
(	NULL
Ziifniga-Pfliicker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

A	NULL
wide	NULL
variety	NULL
of	NULL
DNA	NULL
transfection	NULL
protocols	NULL
have	NULL
been	NULL
developed	NULL
,	NULL
such	NULL
as	NULL
the	NULL
use	NULL
of	NULL
retroviruses	NULL
,	NULL
liposomes	NULL
,	NULL
adenoviruses	NULL
,	NULL
gene	NULL
gun-bombardment	NULL
,	NULL
and	NULL
electroporation	NULL
(	NULL
Crompton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Michie	NULL
and	NULL
Ziuniga-Pfliicker	NULL
,	NULL
2000	NULL
;	NULL
Rooke	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Sugawara	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Suzuki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ziifiiga-Pfliicker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
approaches	NULL
has	NULL
its	NULL
own	NULL
merits	NULL
and	NULL
drawbacks	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
stage	NULL
of	NULL
development	NULL
being	NULL
studied	NULL
and	NULL
the	NULL
type	NULL
of	NULL
assay	NULL
system	NULL
employed	NULL
for	NULL
analytical	NULL
readout	NULL
.	NULL

Retroviral	NULL
infection	NULL
of	NULL
early	NULL
fetal	NULL
thymocytes	NULL
allowed	NULL
for	NULL
stable	NULL
expression	NULL
of	NULL
transduced	NULL
genes	NULL
during	NULL
thymocyte	NULL
differentiation	NULL
(	NULL
Crompton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Pallard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
;	NULL
Sugawara	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Crompton	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
,	NULL
achieved	NULL
this	NULL
by	NULL
directly	NULL
infecting	NULL
fetal	NULL
thymic	NULL
lobes	NULL
,	NULL
and	NULL
Sugawara	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
reconstituted	NULL
fetal	NULL
thymic	NULL
lobes	NULL
with	NULL
thymocytes	NULL
infected	NULL
by	NULL
coculture	NULL
with	NULL
a	NULL
retroviral	NULL
packaging	NULL
cell	NULL
line	NULL
.	NULL

Rooke	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
used	NULL
adenovirus-mediated	NULL
infection	NULL
to	NULL
transduce	NULL
thymic	NULL
stroma	NULL
,	NULL
as	NULL
these	NULL
quiescent	NULL
cells	NULL
are	NULL
not	NULL
susceptible	NULL
to	NULL
retroviral	NULL
infection	NULL
.	NULL

Electroporation	NULL
of	NULL
thymocytes	NULL
has	NULL
also	NULL
been	NULL
carried	NULL
out	NULL
,	NULL
and	NULL
has	NULL
the	NULL
advantage	NULL
of	NULL
being	NULL
easily	NULL
applicable	NULL
to	NULL
thymocytes	NULL
in	NULL
cell	NULL
suspension	NULL
(	NULL
Michie	NULL
and	NULL
Zufiga-Pfliicker	NULL
,	NULL
2000	NULL
;	NULL
Nickoloff	NULL
,	NULL
1995	NULL
;	NULL
Zdfiiga-Pfliicker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
allowing	NULL
for	NULL
the	NULL
isolation	NULL
,	NULL
by	NULL
flow	NULL
cytometry	NULL
cell	NULL
sorting	NULL
or	NULL
magnetic	NULL
bead	NULL
separation	NULL
,	NULL
of	NULL
a	NULL
particular	NULL
target	NULL
population	NULL
of	NULL
thymocytes	NULL
to	NULL
be	NULL
transfected	NULL
.	NULL

Previous	NULL
innovations	NULL
in	NULL
tissue	NULL
culture	NULL
techniques	NULL
resulted	NULL
in	NULL
the	NULL
creation	NULL
of	NULL
an	NULL
in	NULL
vitro	NULL
T-cell	NULL
development	NULL
system	NULL
that	NULL
is	NULL
amenable	NULL
to	NULL
controlled	NULL
experi-mentation	NULL
;	NULL
this	NULL
technique	NULL
is	NULL
known	NULL
as	NULL
the	NULL
fetal	NULL
thymic	NULL
organ	NULL
culture	NULL
(	NULL
FTOC	NULL
)	NULL
(	NULL
Anderson	NULL
and	NULL
Jenkinson	NULL
,	NULL
1998	NULL
;	NULL
Anderson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

FTOC	NULL
's	NULL
involve	NULL
the	NULL
culturing	NULL
of	NULL
thymic	NULL
lobes	NULL
in	NULL
an	NULL
air-liquid	NULL
interphase	NULL
,	NULL
providing	NULL
favorable	NULL
conditions	NULL
for	NULL
normal	NULL
growth	NULL
and	NULL
differentiation	NULL
(	NULL
Jenkinson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1982	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
thymocytes	NULL
grown	NULL
in	NULL
standard	NULL
suspension	NULL
cultures	NULL
,	NULL
which	NULL
normally	NULL
undergo	NULL
rapid	NULL
apoptotic	NULL
death	NULL
,	NULL
FTOCs	NULL
maintain	NULL
an	NULL
intact	NULL
thymic	NULL
stromal	NULL
architec-ture	NULL
,	NULL
thus	NULL
providing	NULL
an	NULL
appropriate	NULL
environment	NULL
for	NULL
thymocyte	NULL
differentiation	NULL
(	NULL
Anderson	NULL
and	NULL
Jenkinson	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
FTOC	NULL
system	NULL
allows	NULL
for	NULL
the	NULL
study	NULL
of	NULL
thymocyte	NULL
development	NULL
within	NULL
its	NULL
natural	NULL
physiological	NULL
in	NULL
vivo	NULL
setting	NULL
.	NULL

We	NULL
have	NULL
developed	NULL
an	NULL
approach	NULL
that	NULL
uses	NULL
an	NULL
accelerated	NULL
DNA/particle	NULL
bombardment	NULL
(	NULL
gene	NULL
gun	NULL
)	NULL
delivery	NULL
system	NULL
to	NULL
transfect	NULL
thymocytes	NULL
in	NULL
FTOC	NULL
(	NULL
ZGuniga-Pfliicker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
have	NULL
combined	NULL
this	NULL
non	NULL
invasive	NULL
means	NULL
of	NULL
DNA	NULL
delivery	NULL
into	NULL
thymocytes	NULL
with	NULL
a	NULL
novel	NULL
reporter-plasmid	NULL
system	NULL
,	NULL
which	NULL
allows	NULL
intracellular	NULL
signaling	NULL
cascades	NULL
to	NULL
be	NULL
monitored	NULL
via	NULL
reporter-gene	NULL
plasmids	NULL
,	NULL
such	NULL
as	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
characterized	NULL
the	NULL
optimal	NULL
conditions	NULL
with	NULL
which	NULL
to	NULL
study	NULL
two	NULL
signaling	NULL
pathways	NULL
within	NULL
thymic	NULL
lobes	NULL
,	NULL
involving	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
and	NULL
CREB-mediated	NULL
signaling	NULL
pathways	NULL
through	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
PKA	NULL
)	NULL
.	NULL

The	NULL
introduction	NULL
of	NULL
reporter-plasmids	NULL
into	NULL
thymic	NULL
lobes	NULL
without	NULL
disrupting	NULL
the	NULL
thymic	NULL
microenvironment	NULL
permits	NULL
the	NULL
study	NULL
of	NULL
biochemical	NULL
signaling	NULL
events	NULL
in	NULL
real	NULL
time	NULL
and	NULL
within	NULL
a	NULL
relevant	NULL
biological	NULL
setting	NULL
.	NULL

DETECTION	NULL
OF	NULL
CELL	NULL
SIGNALS	NULL
IN	NULL
FTOC	NULL
33	NULL
RESULTS	NULL
Detection	NULL
of	NULL
Intracellular	NULL
Signaling	NULL
Pathways	NULL
with	NULL
Reporter-Plasmids	NULL
The	NULL
cellular	NULL
signaling	NULL
processes	NULL
that	NULL
govern	NULL
developmental	NULL
checkpoints	NULL
during	NULL
T-cell	NULL
maturation	NULL
within	NULL
the	NULL
thymus	NULL
are	NULL
not	NULL
well	NULL
defined	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
have	NULL
developed	NULL
a	NULL
technique	NULL
that	NULL
combines	NULL
gene	NULL
gun-mediated	NULL
transfection	NULL
of	NULL
FTOCs	NULL
with	NULL
reporter-plasmids	NULL
that	NULL
allows	NULL
intracellular	NULL
signaling	NULL
cascades	NULL
to	NULL
be	NULL
monitored	NULL
in	NULL
an	NULL
in	NULL
vivo	NULL
setting	NULL
and	NULL
in	NULL
a	NULL
biological	NULL
time	NULL
frame	NULL
.	NULL

A	NULL
novel	NULL
system	NULL
for	NULL
the	NULL
in	NULL
vivo	NULL
detection	NULL
of	NULL
different	NULL
signal	NULL
transduction	NULL
pathways	NULL
,	NULL
such	NULL
as	NULL
those	NULL
involving	NULL
MAPK	NULL
and	NULL
PKA	NULL
,	NULL
involves	NULL
the	NULL
use	NULL
of	NULL
commercially	NULL
available	NULL
reporter-plasmids	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
approach	NULL
takes	NULL
advantage	NULL
of	NULL
three	NULL
plasmids	NULL
:	NULL
the	NULL
first	NULL
one	NULL
encodes	NULL
for	NULL
a	NULL
fusion	NULL
protein	NULL
containing	NULL
an	NULL
activation	NULL
domain	NULL
derived	NULL
from	NULL
the	NULL
specific	NULL
substrate	NULL
recognition	NULL
site	NULL
for	NULL
each	NULL
kinase	NULL
(	NULL
pFA-Elk	NULL
or	NULL
pFA2-CREB	NULL
)	NULL
and	NULL
a	NULL
DNA-binding	NULL
protein	NULL
domain	NULL
derived	NULL
from	NULL
the	NULL
yeast	NULL
DNA	NULL
transcriptional	NULL
activator	NULL
GAL4	NULL
;	NULL
the	NULL
second	NULL
plasmid	NULL
encodes	NULL
for	NULL
the	NULL
luciferase	NULL
gene	NULL
controlled	NULL
by	NULL
five	NULL
repeats	NULL
of	NULL
a	NULL
GALA4-binding	NULL
element	NULL
followed	NULL
by	NULL
a	NULL
basic	NULL
transcriptional	NULL
promoter	NULL
{	NULL
TATATA	NULL
)	NULL
(	NULL
pFR-Luc	NULL
)	NULL
;	NULL
the	NULL
third	NULL
plasmid	NULL
provides	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
encoding	NULL
for	NULL
constitutively	NULL
active	NULL
version	NULL
of	NULL
the	NULL
kinase	NULL
to	NULL
be	NULL
tested	NULL
(	NULL
pFC-MEK1	NULL
or	NULL
pFC-PKA	NULL
)	NULL
,	NULL
which	NULL
is	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
strong	NULL
enhancer/promoter	NULL
elements	NULL
.	NULL

When	NULL
the	NULL
fusion-activator	NULL
and	NULL
luciferase-reporter	NULL
plasmids	NULL
are	NULL
cotransfected	NULL
-	NULL
into	NULL
-	NULL
mammalian	NULL
-	NULL
cells	NULL
,	NULL
-	NULL
activa-tion-induced	NULL
phosphorylation	NULL
of	NULL
the	NULL
fusion-activator	NULL
protein	NULL
by	NULL
its	NULL
cognate	NULL
kinase	NULL
results	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
from	NULL
the	NULL
pFR-Luc	NULL
reporter-plasmid	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
activa-tion-induced	NULL
intracellular	NULL
signal	NULL
can	NULL
be	NULL
measured	NULL
by	NULL
carrying	NULL
out	NULL
a	NULL
standard	NULL
luciferase	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

To	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
,	NULL
thymocytes	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
plasmid	NULL
encoding	NULL
B-galactosi-dase	NULL
,	NULL
which	NULL
is	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
promoter/enhancer	NULL
.	NULL

The	NULL
B-galactosidase	NULL
activity	NULL
is	NULL
used	NULL
to	NULL
index	NULL
the	NULL
luciferase	NULL
signal	NULL
obtained	NULL
from	NULL
each	NULL
sample	NULL
,	NULL
as	NULL
assays	NULL
for	NULL
luci-	NULL
ferase	NULL
and	NULL
B-galactosidase	NULL
activity	NULL
can	NULL
be	NULL
performed	NULL
within	NULL
the	NULL
same	NULL
sample	NULL
tube	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

This	NULL
is	NULL
accomplished	NULL
using	NULL
a	NULL
novel	NULL
detection	NULL
system	NULL
,	NULL
in	NULL
which	NULL
both	NULL
enzymatic	NULL
reactions	NULL
are	NULL
measured	NULL
in	NULL
the	NULL
form	NULL
of	NULL
light	NULL
emission	NULL
;	NULL
that	NULL
is	NULL
luciferase	NULL
on	NULL
the	NULL
catalytic	NULL
breakdown	NULL
of	NULL
the	NULL
substrate	NULL
luciferin	NULL
,	NULL
and	NULL
B-galactosidase	NULL
on	NULL
catalysis	NULL
of	NULL
the	NULL
substrate	NULL
Galac-ton-Plus	NULL
.	NULL

Detection	NULL
of	NULL
Signaling	NULL
Pathways	NULL
in	NULL
Stimulated	NULL
EL4	NULL
Cells	NULL
Our	NULL
first	NULL
aim	NULL
was	NULL
to	NULL
demonstrate	NULL
that	NULL
the	NULL
reporter-plasmids	NULL
were	NULL
responsive	NULL
to	NULL
known	NULL
inducers	NULL
of	NULL
MAPK	NULL
or	NULL
CREB-mediated	NULL
pathways	NULL
.	NULL

Initially	NULL
,	NULL
we	NULL
used	NULL
electroporation	NULL
to	NULL
transfect	NULL
MAPK-signaling	NULL
reporter-plasmids	NULL
into	NULL
ELA	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
fusion-activator	NULL
plasmid	NULL
,	NULL
pFA-Elk	NULL
and	NULL
the	NULL
luciferase	NULL
reporter-plasmid	NULL
,	NULL
pFR-Luc	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
phorbol	NULL
ester	NULL
,	NULL
phor-bol-12-myristate-13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
and	NULL
the	NULL
calcium	NULL
ionophore	NULL
,	NULL
ionomycin	NULL
show	NULL
an	NULL
induction	NULL
(	NULL
>	NULL
200	NULL
fold	NULL
)	NULL
of	NULL
luciferase	NULL
activity	NULL
,	NULL
as	NULL
compared	NULL
to	NULL
control	NULL
untreated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
MAPK-signaling	NULL
cascade	NULL
can	NULL
be	NULL
detected	NULL
following	NULL
stimulation	NULL
with	NULL
PMA/ionomycin	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
cells	NULL
co-transfected	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
a	NULL
constitutively	NULL
active	NULL
MEK1	NULL
,	NULL
pFC-MEK1	NULL
showed	NULL
maximal	NULL
luciferase	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
exogenous	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
have	NULL
previously	NULL
demonstrated	NULL
that	NULL
the	NULL
transfection	NULL
of	NULL
thymocyte	NULL
suspensions	NULL
with	NULL
pFA-Elk	NULL
and	NULL
pFR-Luc	NULL
,	NULL
and	NULL
subsequent	NULL
stimulation	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
PMA/ionomycin	NULL
led	NULL
to	NULL
a	NULL
similar	NULL
activation	NULL
of	NULL
luciferase	NULL
activity	NULL
(	NULL
Michie	NULL
and	NULL
Zaniga-Pfliicker	NULL
,	NULL
2000	NULL
)	NULL
.	NULL

In	NULL
a	NULL
similar	NULL
fashion	NULL
,	NULL
we	NULL
transfected	NULL
PKA-signaling	NULL
reporter-plasmids	NULL
into	NULL
ELA	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
ELA	NULL
cells	NULL
transfected	NULL
with	NULL
pFA2-CREB-	NULL
and	NULL
pFR-Luc-plasmids	NULL
elicited	NULL
a	NULL
greater	NULL
than	NULL
ten	NULL
fold	NULL
stimulation	NULL
of	NULL
luciferase	NULL
activity	NULL
upon	NULL
addition	NULL
of	NULL
the	NULL
adenylyl	NULL
cyclase	NULL
activator	NULL
,	NULL
forskolin	NULL
,	NULL
as	NULL
compared	NULL
to	NULL
control	NULL
untreated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2b	NULL
)	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
cells	NULL
co-transfected	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
a	NULL
constitutively	NULL
active	NULL
PKA	NULL
,	NULL
pFC-PKA	NULL
showed	NULL
a	NULL
maximal	NULL
34	NULL
ALISON	NULL
M.	NULL
MICHIE	NULL
and	NULL
JUAN	NULL
CARLOS	NULL
ZUNIGA-PFLUCKER	NULL
CMV	NULL
|	NULL
[	NULL
Afizactive	NULL
-	NULL
(	NULL
Optional	NULL
)	NULL
Constitutively	NULL
Active	NULL
Kinase	NULL
AL4	NULL
d	NULL
i	NULL
GALA	NULL
UA	NULL
TTA	NULL
Luciferase	NULL
Pathway-specific	NULL
fusion	NULL
I	NULL
Reporter-plasmid	NULL
trans-activator	NULL
protein	NULL
Gene	NULL
gun	NULL
El	NULL
A	NULL
.	NULL

Gh	NULL
nnn	NULL
an	NULL
me	NULL
a	NULL
ectroporate	NULL
plasmids	NULL
(	NULL
@	NULL
)	NULL
©	NULL
.	NULL

2	NULL
ge	NULL
,	NULL
*08	NULL
,	NULL
®	NULL
,0	NULL
into	NULL
EL4	NULL
cells	NULL
fetal	NULL
thymic	NULL
lobes	NULL
C	NULL
~	NULL
De	NULL
novo	NULL
signal	NULL
leads	NULL
to	NULL
the	NULL
phosphorylation	NULL
of	NULL
pathway-specific	NULL
frans-activator	NULL
Pathway	NULL
specific	NULL
kinase	NULL
Phosphorylated	NULL
trans-activator	NULL
binds	NULL
Po	NULL
to	NULL
GAL4	NULL
UAS	NULL
and	NULL
activates	NULL
4	NULL
Luciferase	NULL
expression	NULL
Assay	NULL
for	NULL
Luciferase	NULL
FIGURE	NULL
1	NULL
/n	NULL
vivo	NULL
signal	NULL
transduction	NULL
pathway	NULL
reporting	NULL
systems	NULL
.	NULL

This	NULL
experimental	NULL
system	NULL
takes	NULL
advantage	NULL
of	NULL
three	NULL
plasmids	NULL
:	NULL
the	NULL
first	NULL
plasmid	NULL
encodes	NULL
for	NULL
a	NULL
fusion	NULL
protein	NULL
containing	NULL
an	NULL
activation	NULL
domain	NULL
derived	NULL
from	NULL
the	NULL
specific	NULL
substrate	NULL
recognition	NULL
site	NULL
for	NULL
each	NULL
kinase	NULL
(	NULL
eg	NULL
.	NULL

,	NULL
pFA-Elk	NULL
for	NULL
MAPK	NULL
and	NULL
pFA2-CREB	NULL
for	NULL
PKA	NULL
)	NULL
and	NULL
a	NULL
DNA	NULL
binding	NULL
protein	NULL
domain	NULL
derived	NULL
from	NULL
the	NULL
yeast	NULL
DNA	NULL
transcriptional	NULL
activator	NULL
GALA	NULL
;	NULL
the	NULL
second	NULL
plasmid	NULL
encodes	NULL
for	NULL
the	NULL
luciferase	NULL
gene	NULL
controlled	NULL
by	NULL
five	NULL
repeats	NULL
of	NULL
GAL4	NULL
binding	NULL
element	NULL
followed	NULL
by	NULL
a	NULL
basic	NULL
transcriptional	NULL
promoter	NULL
(	NULL
TATATA	NULL
;	NULL
pFR-Luc	NULL
)	NULL
;	NULL
the	NULL
third	NULL
plasmid	NULL
is	NULL
the	NULL
gene	NULL
of	NULL
interest	NULL
or	NULL
a	NULL
positive	NULL
control	NULL
encoding	NULL
for	NULL
constitutively	NULL
active	NULL
versions	NULL
of	NULL
each	NULL
of	NULL
the	NULL
kinases	NULL
to	NULL
be	NULL
tested	NULL
,	NULL
which	NULL
are	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
strong	NULL
enhancer/promoter	NULL
elements	NULL
(	NULL
pFC-MEK1	NULL
and	NULL
pFC-PKA	NULL
)	NULL
.	NULL

When	NULL
the	NULL
fusion-activator	NULL
plasmid	NULL
luciferase-reporter	NULL
plasmid	NULL
are	NULL
cotransfected	NULL
into	NULL
mammalian	NULL
cells	NULL
,	NULL
phosphorylation	NULL
of	NULL
the	NULL
fusion-activator	NULL
protein	NULL
by	NULL
its	NULL
cognate	NULL
kinase	NULL
leads	NULL
to	NULL
the	NULL
transcriptional	NULL
activation	NULL
luciferase	NULL
gene	NULL
from	NULL
the	NULL
reporter	NULL
plasmid	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
signal	NULL
can	NULL
be	NULL
measured	NULL
by	NULL
carrying	NULL
out	NULL
a	NULL
standard	NULL
luciferase	NULL
assay	NULL
luciferase	NULL
activity	NULL
with	NULL
or	NULL
without	NULL
the	NULL
addition	NULL
of	NULL
for-	NULL
To	NULL
demonstrate	NULL
that	NULL
these	NULL
plasmids	NULL
provided	NULL
a	NULL
sen-skolin	NULL
(	NULL
>	NULL
40	NULL
fold	NULL
;	NULL
Fig	NULL
.	NULL

2b	NULL
)	NULL
.	NULL

sitive	NULL
readout	NULL
for	NULL
biological	NULL
events	NULL
,	NULL
such	NULL
as	NULL
anti	NULL
DETECTION	NULL
OF	NULL
CELL	NULL
SIGNALS	NULL
IN	NULL
FTOC	NULL
35	NULL
MAPK	NULL
signalling	NULL
plasmids	NULL
PK	NULL
A-signalling	NULL
plasmids	NULL
a.	NULL
b	NULL
.	NULL

10000	NULL
~	NULL
1000	NULL
[	NULL
]	NULL
Control	NULL
[	NULL
[	NULL
J	NULL
Control	NULL
1000	NULL
<	NULL
j	NULL
PMA/ionomycin	NULL
§§	NULL
Forskolin	NULL
E=	NULL
[	NULL
=	NULL
8	NULL
3	NULL
100	NULL
4	NULL
3	NULL
e	NULL
£	NULL
E	NULL
2	NULL
-	NULL
100	NULL
4	NULL
§	NULL
3	NULL
3	NULL
(	NULL
s	NULL
a	NULL
e	NULL
B	NULL
I-	NULL
$	NULL
0	NULL
104	NULL
10	NULL
4	NULL
3	NULL
1	NULL
.	NULL

t	NULL
1	NULL
m	NULL
R	NULL
pFR-lue	NULL
-	NULL
+	NULL
pFA-Elk	NULL
-	NULL
+	NULL
pPCMEK1I	NULL
pPR-Juc	NULL
-	NULL
+	NULL
pFAZ-CREB	NULL
-	NULL
+pFC-PKA	NULL
¢	NULL
.	NULL

d.	NULL
300	NULL
-	NULL
40	NULL
250	NULL
-	NULL
a	NULL
[	NULL
]	NULL
Control	NULL
30	NULL
4	NULL
[	NULL
]	NULL
J	NULL
Control	NULL
go	NULL
2	NULL
@	NULL
7	NULL
M	NULL
aCD2-stimulated	NULL
s	NULL
M	NULL
2C	NULL
)	NULL
stimulated	NULL
&	NULL
B	NULL
E	NULL
§	NULL
€	NULL
aso	NULL
4	NULL
&	NULL
204	NULL
3	NULL
3	NULL
2	NULL
0	NULL
100	NULL
-	NULL
2	NULL
10	NULL
{	NULL
h	NULL
50	NULL
0	NULL
-	NULL
o	NULL
LL	NULL
pEéR-luc	NULL
+	NULL
pFA-Flk	NULL
pEHR-luc	NULL
+	NULL
pFA2-CREB	NULL
FIGURE	NULL
2	NULL
Activation	NULL
of	NULL
specific	NULL
signaling	NULL
cascades	NULL
upon	NULL
stimulation	NULL
of	NULL
transfected	NULL
EL4	NULL
cells	NULL
with	NULL
pharmacologic	NULL
agents	NULL
or	NULL
anti-CD3	NULL
mon-oclonal	NULL
antibody	NULL
(	NULL
145-2C11	NULL
)	NULL
.	NULL

ELA	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
reporter-plasmids	NULL
as	NULL
indicated	NULL
.	NULL

MAPK-signaling	NULL
plasmid	NULL
transfections	NULL
are	NULL
shown	NULL
in	NULL
(	NULL
a	NULL
)	NULL
and	NULL
(	NULL
c	NULL
)	NULL
,	NULL
and	NULL
PKA-signalling	NULL
plasmid	NULL
transfections	NULL
are	NULL
shown	NULL
in	NULL
(	NULL
b	NULL
)	NULL
and	NULL
(	NULL
d	NULL
)	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
incubated	NULL
overnight	NULL
at	NULL
37°C	NULL
and	NULL
then	NULL
stimulated	NULL
for	NULL
6	NULL
hr	NULL
with	NULL
:	NULL
(	NULL
a	NULL
)	NULL
PMA/ionomycin	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
;	NULL
(	NULL
b	NULL
)	NULL
forskolin	NULL
(	NULL
20	NULL
ug/m1	NULL
)	NULL
;	NULL
or	NULL
(	NULL
c	NULL
)	NULL
and	NULL
(	NULL
d	NULL
)	NULL
plate-bound	NULL
anti-CD3	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
and	NULL
the	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

In	NULL
each	NULL
of	NULL
the	NULL
conditions	NULL
,	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
fusion-activator	NULL
plasmids	NULL
,	NULL
pFA-Elk	NULL
or	NULL
pFA2-CREB	NULL
,	NULL
and	NULL
the	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
,	NULL
pFR-Luc	NULL
,	NULL
leads	NULL
to	NULL
an	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
,	NULL
compared	NULL
to	NULL
unstimulated	NULL
cells	NULL
.	NULL

Positive	NULL
control	NULL
cells	NULL
transfected	NULL
with	NULL
(	NULL
a	NULL
)	NULL
an	NULL
active	NULL
MEK	NULL
1-plasmid	NULL
,	NULL
pFC-MEK	NULL
1	NULL
,	NULL
or	NULL
(	NULL
b	NULL
)	NULL
an	NULL
active	NULL
PKA-plasmid	NULL
,	NULL
pFC-PKA	NULL
,	NULL
both	NULL
show	NULL
maximal	NULL
luciferase	NULL
activity	NULL
with	NULL
or	NULL
without	NULL
stimulation	NULL
,	NULL
whereas	NULL
only	NULL
background	NULL
luciferase	NULL
activity	NULL
is	NULL
detected	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
pFR-Luc	NULL
alone	NULL
body-mediated	NULL
engagement	NULL
of	NULL
the	NULL
TCR/CD3	NULL
fusion-activator	NULL
plasmids	NULL
,	NULL
pFA-Elk	NULL
or	NULL
pFA2-CREB	NULL
,	NULL
complex	NULL
,	NULL
we	NULL
transfected	NULL
ELA	NULL
cells	NULL
with	NULL
the	NULL
luciferase	NULL
to	NULL
readout	NULL
the	NULL
activation	NULL
of	NULL
MAPK-	NULL
or	NULL
CREB-medi-reporter-plasmid	NULL
(	NULL
pFR-Luc	NULL
)	NULL
and	NULL
either	NULL
of	NULL
the	NULL
ated	NULL
pathways	NULL
,	NULL
respectively	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
36	NULL
ALISON	NULL
M.	NULL
MICHIE	NULL
and	NULL
JUAN	NULL
CARLOS	NULL
ZUNIGA-PFLUCKER	NULL
engagement	NULL
of	NULL
the	NULL
TCR/CD3	NULL
complex	NULL
,	NULL
with	NULL
plate	NULL
bound	NULL
anti-CD3-mAb	NULL
(	NULL
145-2C11	NULL
)	NULL
,	NULL
led	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
both	NULL
MAPK-	NULL
and	NULL
CREB-mediated	NULL
signaling	NULL
cascades	NULL
(	NULL
Figs	NULL
.	NULL

2¢	NULL
and	NULL
d	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
aggregation	NULL
of	NULL
the	NULL
TCR/CD3	NULL
complex	NULL
in	NULL
pFA-Elk-transfected	NULL
cells	NULL
showed	NULL
an	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
(	NULL
>	NULL
ten	NULL
fold	NULL
)	NULL
,	NULL
compared	NULL
to	NULL
unstimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2¢	NULL
)	NULL
,	NULL
while	NULL
nearly	NULL
a	NULL
four	NULL
fold	NULL
stimulation	NULL
in	NULL
luciferase	NULL
activity	NULL
was	NULL
observed	NULL
in	NULL
pFA2-CREB-transfected	NULL
cell	NULL
(	NULL
Fig	NULL
.	NULL

2d	NULL
)	NULL
.	NULL

Gene	NULL
Gun-Mediated	NULL
Transfection	NULL
of	NULL
FTOCs	NULL
As	NULL
previously	NULL
stated	NULL
,	NULL
our	NULL
aim	NULL
is	NULL
to	NULL
employ	NULL
the	NULL
reporter-plasmids	NULL
to	NULL
obtain	NULL
a	NULL
sensitive	NULL
readout	NULL
of	NULL
signaling	NULL
events	NULL
that	NULL
occur	NULL
during	NULL
thymocyte	NULL
maturation	NULL
and	NULL
differentiation	NULL
.	NULL

Thus	NULL
,	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
fetal	NULL
thymic	NULL
lobes	NULL
from	NULL
day	NULL
14	NULL
timed-pregnant	NULL
CD1	NULL
mice	NULL
as	NULL
targets	NULL
for	NULL
gene	NULL
gun-mediated	NULL
plasmid	NULL
transfection	NULL
with	NULL
a	NULL
Helios	NULL
Gene	NULL
Gun	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Our	NULL
previous	NULL
experiments	NULL
have	NULL
shown	NULL
that	NULL
accelerated	NULL
DNA/gold	NULL
particles	NULL
can	NULL
transfect	NULL
thymocytes	NULL
to	NULL
a	NULL
depth	NULL
of	NULL
six	NULL
to	NULL
eight	NULL
cell	NULL
layers	NULL
in	NULL
the	NULL
thymus	NULL
(	NULL
ZGdfiiga-Pfliicker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
FTOCs	NULL
with	NULL
a	NULL
plasmid	NULL
encoding	NULL
for	NULL
green	NULL
fluorescent	NULL
protein	NULL
(	NULL
GFP	NULL
)	NULL
bound	NULL
to	NULL
gold	NULL
particles	NULL
allowed	NULL
us	NULL
to	NULL
determine	NULL
the	NULL
transfection	NULL
efficiency	NULL
of	NULL
thymocytes	NULL
within	NULL
fetal	NULL
thymic	NULL
lobes	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
thymic	NULL
suspensions	NULL
obtained	NULL
from	NULL
gene	NULL
gun-transfected	NULL
FTOCs	NULL
showed	NULL
a	NULL
transfection	NULL
efficiency	NULL
of	NULL
0.8-3	NULL
%	NULL
GFP*	NULL
thymocytes	NULL
.	NULL

The	NULL
proportion	NULL
of	NULL
thymocytes	NULL
transfected	NULL
was	NULL
determined	NULL
by	NULL
staining	NULL
cell	NULL
suspensions	NULL
with	NULL
a	NULL
leukocyte-specific	NULL
marker	NULL
(	NULL
CD45	NULL
)	NULL
and	NULL
analyzing	NULL
for	NULL
GFP*	NULL
cells	NULL
within	NULL
the	NULL
CD45*	NULL
population	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
.	NULL

This	NULL
analysis	NULL
demonstrates	NULL
that	NULL
the	NULL
GFP*	NULL
cells	NULL
represent	NULL
developing	NULL
thymocytes	NULL
rather	NULL
than	NULL
thymic	NULL
stromal	NULL
elements	NULL
,	NULL
such	NULL
as	NULL
the	NULL
epithelial	NULL
cells	NULL
encasing	NULL
the	NULL
thymus	NULL
or	NULL
cortical	NULL
epithelial	NULL
cells	NULL
within	NULL
the	NULL
fetal	NULL
thymus	NULL
.	NULL

Figure	NULL
3a	NULL
shows	NULL
GFP	NULL
expression	NULL
is	NULL
evident	NULL
in	NULL
1.2	NULL
%	NULL
of	NULL
the	NULL
CD45*	NULL
leukocyte	NULL
population	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
FTOC	NULL
transfection	NULL
by	NULL
DNA/gold	NULL
particle	NULL
bombardment	NULL
,	NULL
when	NULL
combined	NULL
with	NULL
the	NULL
reporter-plasmids	NULL
provides	NULL
a	NULL
reliable	NULL
and	NULL
sensitive	NULL
assay	NULL
system	NULL
,	NULL
we	NULL
transfected	NULL
thymic	NULL
lobes	NULL
with	NULL
plasmids-encoding	NULL
luciferase	NULL
and	NULL
B-galactosi-	NULL
dase	NULL
,	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
CMV	NULL
pro-moter/enhancer	NULL
elements	NULL
.	NULL

Eighteen	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
a	NULL
35-fold	NULL
elevation	NULL
in	NULL
luciferase	NULL
activity	NULL
was	NULL
observed	NULL
,	NULL
as	NULL
compared	NULL
to	NULL
mock-transfected	NULL
lobes	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
B-galactosidase	NULL
activity	NULL
was	NULL
elevated	NULL
six	NULL
fold	NULL
over	NULL
mock-transfected	NULL
controls	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
.	NULL

It	NULL
is	NULL
apparent	NULL
from	NULL
these	NULL
results	NULL
that	NULL
luciferase	NULL
activity	NULL
provides	NULL
a	NULL
more	NULL
sensitive	NULL
readout	NULL
system	NULL
for	NULL
recording	NULL
the	NULL
activation	NULL
of	NULL
signaling	NULL
pathways	NULL
,	NULL
while	NULL
B-galactosidase	NULL
activity	NULL
exhibits	NULL
a	NULL
robust	NULL
signal	NULL
,	NULL
appropriate	NULL
for	NULL
indexing	NULL
purposes	NULL
.	NULL

Developmental	NULL
Progression	NULL
of	NULL
Transfected	NULL
Thymocytes	NULL
Within	NULL
FTOCs	NULL
To	NULL
further	NULL
examine	NULL
the	NULL
impact	NULL
of	NULL
gene	NULL
gun-transfection	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
thymus	NULL
to	NULL
support	NULL
T	NULL
lym-phopoiesis	NULL
,	NULL
and	NULL
the	NULL
preservation	NULL
of	NULL
the	NULL
thymic	NULL
microenvironment	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
longterm	NULL
developmental	NULL
potential	NULL
of	NULL
transfected	NULL
thymocytes	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
transfected	NULL
recombinase	NULL
activating	NULL
gene-2-deficient	NULL
(	NULL
RAG-2	NULL
``	NULL
~	NULL
)	NULL
mouse	NULL
fetal	NULL
thymic	NULL
lobes	NULL
with	NULL
a	NULL
plasmid	NULL
encoding	NULL
a	NULL
constitutively	NULL
active	NULL
form	NULL
of	NULL
the	NULL
GTPase	NULL
Ras	NULL
,	NULL
(	NULL
p21	NULL
``	NULL
*Y	NULL
'	NULL
)	NULL
(	NULL
Downward	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Swat	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Differentiation	NULL
of	NULL
thymocytes	NULL
from	NULL
RAG-2	NULL
mice	NULL
is	NULL
halted	NULL
at	NULL
the	NULL
CD117	NULL
CD25*	NULL
stage	NULL
,	NULL
prior	NULL
to	NULL
the	NULL
generation	NULL
of	NULL
DP	NULL
cells	NULL
,	NULL
due	NULL
to	NULL
the	NULL
cells	NULL
inability	NULL
to	NULL
initiate	NULL
rearrangement	NULL
of	NULL
their	NULL
TCR-B	NULL
locus	NULL
(	NULL
Shinkai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
introduction	NULL
of	NULL
a	NULL
transgene	NULL
encoding	NULL
an	NULL
active	NULL
Ras	NULL
into	NULL
RAG	NULL
mice	NULL
induces	NULL
cellular	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
CD4	NULL
CD8	NULL
DN	NULL
thymocytes	NULL
to	NULL
the	NULL
CD4*	NULL
CD8*	NULL
DP	NULL
stage	NULL
of	NULL
development	NULL
,	NULL
indicating	NULL
that	NULL
Ras	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
during	NULL
B-selection	NULL
(	NULL
Swat	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
transfection	NULL
of	NULL
thymocytes	NULL
in	NULL
FTOC	NULL
does	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
normal	NULL
thymocyte	NULL
proliferation	NULL
and	NULL
developmental	NULL
progression	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
transition	NULL
through	NULL
B-selection	NULL
,	NULL
RAG-2	NULL
FTOCs	NULL
were	NULL
gene	NULL
gun-transfected	NULL
with	NULL
plasmid	NULL
encoding	NULL
a	NULL
constitutively	NULL
active	NULL
Ras	NULL
.	NULL

FTOCs	NULL
were	NULL
incubated	NULL
for	NULL
9	NULL
days	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

In	NULL
comparison	NULL
to	NULL
the	NULL
mock-transfected	NULL
{	NULL
control	NULL
)	NULL
FTOCs	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
,	NULL
CD25	NULL
expression	NULL
was	NULL
downregulated	NULL
in	NULL
Ras-transfected	NULL
FTOCs	NULL
,	NULL
with	NULL
a	NULL
con	NULL
DETECTION	NULL
OF	NULL
CELL	NULL
SIGNALS	NULL
IN	NULL
FTOC	NULL
37	NULL
a	NULL
.	NULL

No	NULL
DNA	NULL
(	NULL
CD45+	NULL
gated	NULL
)	NULL
GFP	NULL
(	NULL
CD45+	NULL
gated	NULL
)	NULL
Z	NULL
]	NULL
&	NULL
0	NULL
j	NULL
1	NULL
&	NULL
]	NULL
*	NULL
]	NULL
Background	NULL
(	NULL
0	NULL
%	NULL
)	NULL
1	NULL
GFP+	NULL
=	NULL
1.24	NULL
%	NULL
_~	NULL
]	NULL
t	NULL
\|	NULL
T	NULL
4	NULL
GFP	NULL
b.	NULL
no	NULL
DNA	NULL
Rg	NULL
CmVv	NULL
Enzymatic	NULL
activity	NULL
(	NULL
RLUs	NULL
)	NULL
CMV	NULL
-luc	NULL
CMV-B-gal	NULL
FIGURE	NULL
3	NULL
Transfection	NULL
of	NULL
fetal	NULL
thymic	NULL
lobes	NULL
with	NULL
:	NULL
(	NULL
a	NULL
)	NULL
Green	NULL
Fluorescent	NULL
Protein	NULL
(	NULL
GFP	NULL
)	NULL
or	NULL
(	NULL
b	NULL
)	NULL
plasmids	NULL
encoding	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Intact	NULL
fetal	NULL
thymic	NULL
lobes	NULL
removed	NULL
from	NULL
time-pregnant	NULL
CD1	NULL
mice	NULL
(	NULL
day	NULL
13	NULL
of	NULL
gestation	NULL
)	NULL
were	NULL
used	NULL
as	NULL
targets	NULL
for	NULL
DNA-covered	NULL
gold	NULL
particles	NULL
.	NULL

After	NULL
6	NULL
hr	NULL
in	NULL
culture	NULL
on	NULL
nucleopore	NULL
filters	NULL
,	NULL
intact	NULL
lobes	NULL
were	NULL
briefly	NULL
removed	NULL
from	NULL
their	NULL
gel	NULL
foam	NULL
support	NULL
and	NULL
subjected	NULL
to	NULL
bombardment	NULL
by	NULL
accelerated	NULL
DNA/gold	NULL
particles	NULL
(	NULL
200	NULL
psi	NULL
)	NULL
using	NULL
a	NULL
Helios	NULL
Gene	NULL
Gun	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
)	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
intact	NULL
lobes	NULL
were	NULL
transfected	NULL
with	NULL
plasmid	NULL
DNA	NULL
encoding	NULL
GFP	NULL
(	NULL
DLR	NULL
=	NULL
1.5	NULL
ug	NULL
)	NULL
.	NULL

After	NULL
18	NULL
hr	NULL
incubation	NULL
,	NULL
the	NULL
lobes	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
for	NULL
the	NULL
appearance	NULL
of	NULL
GFP	NULL
within	NULL
the	NULL
leukocyte	NULL
population	NULL
of	NULL
cells	NULL
(	NULL
CD45*	NULL
-gated	NULL
)	NULL
.	NULL

Mock	NULL
transfected	NULL
cells	NULL
were	NULL
bombarded	NULL
with	NULL
gold	NULL
particles	NULL
alone	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
representative	NULL
experiment	NULL
of	NULL
GFP	NULL
transfection	NULL
,	NULL
showing	NULL
green	NULL
fluorescence	NULL
in	NULL
1.24	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
within	NULL
the	NULL
lymphocyte	NULL
population	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Transfection	NULL
of	NULL
fetal	NULL
thymic	NULL
lobes	NULL
with	NULL
plasmids	NULL
encoding	NULL
luciferase	NULL
and	NULL
-galactosidase	NULL
.	NULL

Intact	NULL
fetal	NULL
thymic	NULL
lobes	NULL
removed	NULL
from	NULL
timed-pregnant	NULL
CD1	NULL
mice	NULL
(	NULL
day	NULL
14	NULL
of	NULL
gestation	NULL
)	NULL
were	NULL
used	NULL
as	NULL
targets	NULL
for	NULL
DNA-covered	NULL
gold	NULL
particles	NULL
,	NULL
as	NULL
described	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
intact	NULL
lobes	NULL
were	NULL
transfected	NULL
with	NULL
plasmid	NULL
DNA-encoding	NULL
CMV-luciferase	NULL
and	NULL
CMV-B-galactosidase	NULL
(	NULL
DLR	NULL
=	NULL
250	NULL
ng	NULL
)	NULL
.	NULL

After	NULL
18	NULL
hr	NULL
incubation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
the	NULL
resulting	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
there	NULL
is	NULL
a	NULL
35	NULL
fold	NULL
elevation	NULL
in	NULL
luciferase	NULL
activity	NULL
over	NULL
mock	NULL
transfected	NULL
background	NULL
and	NULL
a	NULL
six	NULL
fold	NULL
elevation	NULL
in	NULL
B-galactosidase	NULL
activity	NULL
over	NULL
background	NULL
levels	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
is	NULL
an	NULL
average	NULL
of	NULL
seven	NULL
independent	NULL
experiments	NULL
38	NULL
ALISON	NULL
M.	NULL
MICHIE	NULL
and	NULL
JUAN	NULL
CARLOS	NULL
ZUNIGA-PFLUCKER	NULL
comitant	NULL
upregulation	NULL
of	NULL
both	NULL
CD8	NULL
and	NULL
CD4	NULL
mole-cules	NULL
,	NULL
indicating	NULL
that	NULL
differentiation	NULL
to	NULL
the	NULL
CD4*	NULL
CD8+*	NULL
DP	NULL
stage	NULL
of	NULL
development	NULL
has	NULL
occurred	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
thymic	NULL
cellularity	NULL
was	NULL
evident	NULL
in	NULL
Ras-transfected	NULL
FTOCs	NULL
compared	NULL
with	NULL
mock-transfected	NULL
(	NULL
control	NULL
)	NULL
FTOCs	NULL
(	NULL
2.4	NULL
x	NULL
104	NULL
vs.	NULL
0.56	NULL
x	NULL
104	NULL
cells/lobe	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
gene	NULL
gun-transfection	NULL
does	NULL
not	NULL
impair	NULL
the	NULL
thymic	NULL
microenvironment	NULL
and	NULL
leaves	NULL
the	NULL
thymic	NULL
stromal	NULL
cells	NULL
functionally	NULL
intact	NULL
.	NULL

Indeed	NULL
,	NULL
this	NULL
finding	NULL
mirrors	NULL
the	NULL
developmental	NULL
progression	NULL
observed	NULL
in	NULL
transgenic	NULL
mice	NULL
(	NULL
Swat	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
thus	NULL
supporting	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
thymic	NULL
microenvironment	NULL
and	NULL
the	NULL
signals	NULL
generated	NULL
within	NULL
transfected	NULL
thymocytes	NULL
are	NULL
the	NULL
same	NULL
as	NULL
those	NULL
produced	NULL
in	NULL
vivo	NULL
.	NULL

Detection	NULL
of	NULL
Activated	NULL
Signaling	NULL
Pathways	NULL
in	NULL
FTOC	NULL
's	NULL
In	NULL
order	NULL
to	NULL
define	NULL
the	NULL
conditions	NULL
required	NULL
for	NULL
the	NULL
optimal	NULL
readout	NULL
of	NULL
MAPK-	NULL
and	NULL
PKA-	NULL
signaling	NULL
pathways	NULL
,	NULL
thymic	NULL
lobes	NULL
were	NULL
transfected	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
pFA-Elk	NULL
or	NULL
pFA2-CREB	NULL
plasmids	NULL
,	NULL
while	NULL
maintaining	NULL
constant	NULL
levels	NULL
of	NULL
the	NULL
reporter-	NULL
and	NULL
index-ing-plasmids	NULL
(	NULL
Figs	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
luciferase	NULL
activity	NULL
was	NULL
apparent	NULL
in	NULL
FTOCs	NULL
transfected	NULL
with	NULL
reporter-plasmids	NULL
(	NULL
pFA-Elk	NULL
,	NULL
pFR-Luc	NULL
,	NULL
and	NULL
B-galactosidase	NULL
)	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
PMA/ionomycin	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Although	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
pFA-Elk	NULL
caused	NULL
a	NULL
slight	NULL
elevation	NULL
in	NULL
background	NULL
luciferase	NULL
activity	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
PMA/ionomycin	NULL
to	NULL
transfected	NULL
FTOCs	NULL
led	NULL
to	NULL
a	NULL
clear	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
in	NULL
each	NULL
sample	NULL
.	NULL

Maximum	NULL
stimulation	NULL
of	NULL
luciferase	NULL
activity	NULL
,	NULL
at	NULL
nearly	NULL
three	NULL
fold	NULL
stimulation	NULL
over	NULL
background	NULL
,	NULL
was	NULL
seen	NULL
in	NULL
FTOCs	NULL
transfected	NULL
with	NULL
250	NULL
ng	NULL
of	NULL
pFA-Elk	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

At	NULL
this	NULL
amount	NULL
,	NULL
the	NULL
ratio	NULL
between	NULL
-	NULL
fusion-activator-	NULL
-	NULL
and	NULL
-	NULL
reporter-plasmids	NULL
(	NULL
pFA-Elk	NULL
:	NULL
pFR-Luc	NULL
)	NULL
is	NULL
1:1	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
two	NULL
plasmids	NULL
should	NULL
be	NULL
used	NULL
at	NULL
this	NULL
ratio	NULL
to	NULL
gain	NULL
optimal	NULL
readout	NULL
of	NULL
the	NULL
MAPK	NULL
signalling	NULL
cascade	NULL
in	NULL
fetal	NULL
thymic	NULL
lobes	NULL
.	NULL

Similarly	NULL
,	NULL
we	NULL
have	NULL
defined	NULL
the	NULL
optimal	NULL
conditions	NULL
for	NULL
detecting	NULL
CRER-mediated	NULL
signals	NULL
in	NULL
thymocytes	NULL
within	NULL
thymic	NULL
lobes	NULL
.	NULL

FTOCs	NULL
were	NULL
transfected	NULL
by	NULL
DNA/gold	NULL
bombardment	NULL
-	NULL
with	NULL
-	NULL
reporter-plasmids	NULL
(	NULL
pFAZ-CREB	NULL
,	NULL
pFR-Luc	NULL
and	NULL
B-galactosidase	NULL
)	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
forskolin	NULL
.	NULL

The	NULL
lobes	NULL
were	NULL
transfected	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
pFA2-CREB	NULL
while	NULL
keeping	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
other	NULL
plasmids	NULL
constant	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

An	NULL
elevation	NULL
in	NULL
background	NULL
luciferase	NULL
activity	NULL
was	NULL
not	NULL
evident	NULL
on	NULL
increasing	NULL
the	NULL
concentration	NULL
of	NULL
pFA2Z-CREB	NULL
plasmid	NULL
.	NULL

However	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
forskolin	NULL
led	NULL
to	NULL
a	NULL
significant	NULL
stimulation	NULL
of	NULL
luciferase	NULL
activity	NULL
in	NULL
every	NULL
sample	NULL
,	NULL
with	NULL
the	NULL
maximum	NULL
induction	NULL
(	NULL
>	NULL
four	NULL
fold	NULL
stimulation	NULL
)	NULL
detected	NULL
at	NULL
75	NULL
ng	NULL
of	NULL
pFA2-CREB	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
the	NULL
optimal	NULL
ratio	NULL
of	NULL
pFA2-CREB	NULL
:	NULL
pFR-Luc	NULL
for	NULL
attaining	NULL
maximal	NULL
readout	NULL
of	NULL
PKA	NULL
activity	NULL
in	NULL
fetal	NULL
thymic	NULL
lobes	NULL
is	NULL
0.3:1	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
two	NULL
plasmids	NULL
should	NULL
be	NULL
used	NULL
at	NULL
this	NULL
ratio	NULL
to	NULL
gain	NULL
optimal	NULL
readout	NULL
of	NULL
the	NULL
PKA	NULL
signalling	NULL
cascade	NULL
in	NULL
FTOC	NULL
's	NULL
.	NULL

Our	NULL
findings	NULL
demonstrate	NULL
that	NULL
despite	NULL
the	NULL
low	NULL
transfection	NULL
efficiency	NULL
of	NULL
FTOCs	NULL
by	NULL
gene	NULL
gun-bombardment	NULL
,	NULL
the	NULL
sensitivity	NULL
of	NULL
the	NULL
readout	NULL
system	NULL
clearly	NULL
allows	NULL
for	NULL
the	NULL
study	NULL
of	NULL
biochemical	NULL
signaling	NULL
cascades	NULL
in	NULL
real-time	NULL
and	NULL
in	NULL
a	NULL
relevant	NULL
biological	NULL
setting	NULL
.	NULL

The	NULL
use	NULL
of	NULL
this	NULL
novel	NULL
and	NULL
powerful	NULL
model	NULL
system	NULL
provides	NULL
an	NULL
important	NULL
tool	NULL
for	NULL
the	NULL
further	NULL
elucidation	NULL
of	NULL
signaling	NULL
pathways	NULL
regulating	NULL
key	NULL
checkpoints	NULL
during	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

DISCUSSION	NULL
The	NULL
method	NULL
described	NULL
in	NULL
this	NULL
paper	NULL
relies	NULL
on	NULL
the	NULL
combination	NULL
of	NULL
two	NULL
experimental	NULL
approaches	NULL
:	NULL
(	NULL
1	NULL
)	NULL
a	NULL
reporter-plasmid	NULL
system	NULL
enabling	NULL
the	NULL
detection	NULL
of	NULL
de	NULL
novo	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
in	NULL
vivo	NULL
and	NULL
,	NULL
(	NULL
2	NULL
)	NULL
a	NULL
method	NULL
for	NULL
the	NULL
transfection	NULL
of	NULL
thymocytes	NULL
within	NULL
an	NULL
intact	NULL
thymic	NULL
-	NULL
microenvironment	NULL
(	NULL
Michie	NULL
and	NULL
ZGfiiga-Pfliicker	NULL
,	NULL
2000	NULL
;	NULL
Zuniga-Pfliicker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
have	NULL
developed	NULL
the	NULL
use	NULL
of	NULL
reporter-plasmids	NULL
together	NULL
with	NULL
a	NULL
DNA/particle	NULL
bombardment	NULL
delivery	NULL
system	NULL
to	NULL
transfect	NULL
thymocytes	NULL
in	NULL
FTOC	NULL
,	NULL
permitting	NULL
the	NULL
study	NULL
of	NULL
biochemical	NULL
signaling	NULL
events	NULL
in	NULL
real	NULL
time	NULL
and	NULL
within	NULL
a	NULL
relevant	NULL
biological	NULL
setting	NULL
.	NULL

One	NULL
application	NULL
of	NULL
this	NULL
approach	NULL
involved	NULL
the	NULL
characterization	NULL
of	NULL
MAPK-	NULL
and	NULL
CREB-mediated	NULL
intracellular	NULL
signalling	NULL
pathways	NULL
within	NULL
the	NULL
thymus	NULL
.	NULL

There	NULL
are	NULL
many	NULL
advantages	NULL
of	NULL
this	NULL
transfection	NULL
system	NULL
compared	NULL
with	NULL
other	NULL
methods	NULL
available	NULL
:	NULL
(	NULL
1	NULL
)	NULL
the	NULL
DETECTION	NULL
OF	NULL
CELL	NULL
SIGNALS	NULL
IN	NULL
FOC	NULL
39	NULL
a	NULL
.	NULL

-	NULL
Control	NULL
b	NULL
.	NULL

-	NULL
Constitutively	NULL
active	NULL
Ras-transfected	NULL
CD8	NULL
CD8	NULL
CD4	NULL
FIGURE	NULL
4	NULL
Generation	NULL
of	NULL
CD4+®	NULL
CD8+*	NULL
double	NULL
positive	NULL
cells	NULL
in	NULL
RAG-2	NULL
lobes	NULL
transfected	NULL
with	NULL
constitutively	NULL
active	NULL
Ras	NULL
.	NULL

Intact	NULL
fetal	NULL
thymic	NULL
lobes	NULL
removed	NULL
from	NULL
timed	NULL
pregnant	NULL
RAG-2¢	NULL
mice	NULL
(	NULL
day	NULL
14	NULL
of	NULL
gestation	NULL
)	NULL
were	NULL
used	NULL
as	NULL
targets	NULL
for	NULL
DNA-covered	NULL
gold	NULL
particles	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
fetal	NULL
thymuses	NULL
were	NULL
gene	NULL
gun-transfected	NULL
with	NULL
either	NULL
(	NULL
a	NULL
)	NULL
no	NULL
DNA	NULL
(	NULL
control	NULL
)	NULL
or	NULL
(	NULL
b	NULL
)	NULL
constitutively	NULL
active	NULL
Ras	NULL
(	NULL
Ha-Ras	NULL
(	NULL
V	NULL
12	NULL
)	NULL
;	NULL
DLR	NULL
=	NULL
750	NULL
ng	NULL
)	NULL
,	NULL
and	NULL
then	NULL
cultured	NULL
for	NULL
nine	NULL
days	NULL
in	NULL
FTOC	NULL
.	NULL

After	NULL
this	NULL
time	NULL
,	NULL
a	NULL
single	NULL
cell	NULL
suspension	NULL
of	NULL
the	NULL
fetal	NULL
thymic	NULL
lobes	NULL
was	NULL
prepared	NULL
and	NULL
thymocytes	NULL
were	NULL
analyzed	NULL
for	NULL
surface	NULL
expression	NULL
of	NULL
CD25	NULL
,	NULL
CD8	NULL
and	NULL
CD4	NULL
,	NULL
by	NULL
flow	NULL
cytometry	NULL
specific	NULL
signaling	NULL
cascades	NULL
can	NULL
be	NULL
read	NULL
out	NULL
in	NULL
vivo	NULL
and	NULL
__	NULL
can	NULL
be	NULL
transfected	NULL
simultaneously	NULL
,	NULL
enabling	NULL
the	NULL
study	NULL
within	NULL
the	NULL
thymic	NULL
environment	NULL
;	NULL
(	NULL
2	NULL
)	NULL
multiple	NULL
plasmids	NULL
of	NULL
direct	NULL
or	NULL
indirect	NULL
interactions	NULL
between	NULL
proteins	NULL
;	NULL
(	NULL
3	NULL
)	NULL
40	NULL
ALISON	NULL
M.	NULL
MICHIE	NULL
and	NULL
JUAN	NULL
CARLOS	NULL
ZUNIGA-PFLUCKER	NULL
the	NULL
transfection	NULL
process	NULL
is	NULL
rapid	NULL
and	NULL
without	NULL
apparent	NULL
alteration	NULL
of	NULL
the	NULL
thymic	NULL
microenvironment	NULL
;	NULL
(	NULL
4	NULL
)	NULL
the	NULL
entire	NULL
procedure	NULL
requires	NULL
less	NULL
than	NULL
48	NULL
hours	NULL
to	NULL
com-plete	NULL
;	NULL
(	NULL
5	NULL
)	NULL
this	NULL
method	NULL
offers	NULL
a	NULL
cost-effective	NULL
means	NULL
to	NULL
study	NULL
signaling	NULL
components	NULL
during	NULL
T	NULL
cell	NULL
develop-ment	NULL
;	NULL
(	NULL
6	NULL
)	NULL
the	NULL
amount	NULL
of	NULL
tissue	NULL
required	NULL
is	NULL
small	NULL
(	NULL
4	NULL
to	NULL
6	NULL
fetal	NULL
thymic	NULL
lobes/	NULL
transfection	NULL
)	NULL
;	NULL
(	NULL
7	NULL
)	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
required	NULL
is	NULL
small	NULL
(	NULL
25-250	NULL
ng	NULL
)	NULL
;	NULL
and	NULL
(	NULL
8	NULL
)	NULL
despite	NULL
the	NULL
transient	NULL
nature	NULL
of	NULL
the	NULL
transfection	NULL
,	NULL
it	NULL
may	NULL
be	NULL
possible	NULL
to	NULL
examine	NULL
long	NULL
term	NULL
developmental	NULL
effects	NULL
following	NULL
the	NULL
introduction	NULL
of	NULL
a	NULL
particular	NULL
gene	NULL
at	NULL
a	NULL
specific	NULL
stage	NULL
of	NULL
development	NULL
.	NULL

The	NULL
key	NULL
signaling	NULL
components	NULL
required	NULL
for	NULL
lymphocyte	NULL
development	NULL
have	NULL
been	NULL
largely	NULL
determined	NULL
by	NULL
phenotypic	NULL
and	NULL
molecular	NULL
characterization	NULL
of	NULL
mice	NULL
with	NULL
targeted	NULL
gene	NULL
deficiencies	NULL
,	NULL
and	NULL
by	NULL
the	NULL
introduction	NULL
of	NULL
dominant	NULL
negative	NULL
or	NULL
constitutively	NULL
active	NULL
kinases	NULL
into	NULL
developmentally	NULL
blocked	NULL
mice	NULL
(	NULL
von	NULL
Boehmer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

While	NULL
these	NULL
studies	NULL
have	NULL
provided	NULL
invaluable	NULL
information	NULL
,	NULL
they	NULL
are	NULL
time	NULL
consuming	NULL
,	NULL
costly	NULL
,	NULL
and	NULL
do	NULL
not	NULL
provide	NULL
direct	NULL
and	NULL
detailed	NULL
evidence	NULL
for	NULL
signaling	NULL
mechanisms	NULL
that	NULL
emanate	NULL
from	NULL
the	NULL
gene	NULL
product	NULL
of	NULL
interest	NULL
.	NULL

Our	NULL
gene-gun	NULL
transfection	NULL
technique	NULL
,	NULL
coupled	NULL
with	NULL
the	NULL
reporter-plasmid	NULL
system	NULL
,	NULL
should	NULL
allow	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
signaling	NULL
cascades	NULL
generated	NULL
from	NULL
the	NULL
activation	NULL
of	NULL
upstream	NULL
kinases	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
point	NULL
out	NULL
that	NULL
our	NULL
present	NULL
findings	NULL
validate	NULL
this	NULL
approach	NULL
by	NULL
showing	NULL
that	NULL
transfection	NULL
of	NULL
RAG-deficient	NULL
DN	NULL
thymocytes	NULL
with	NULL
a	NULL
constitutively	NULL
active	NULL
Ras	NULL
induced	NULL
the	NULL
developmental	NULL
progression	NULL
to	NULL
the	NULL
DP	NULL
stage	NULL
,	NULL
and	NULL
thus	NULL
experimentally	NULL
bypassed	NULL
pre-TCR-mediated	NULL
signals	NULL
.	NULL

It	NULL
is	NULL
well	NULL
known	NULL
that	NULL
removal	NULL
of	NULL
thymocytes	NULL
from	NULL
their	NULL
microenvironment	NULL
severely	NULL
interferes	NULL
with	NULL
their	NULL
normal	NULL
developmental	NULL
processes	NULL
and	NULL
leads	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
(	NULL
Fisher	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
perturbation	NULL
of	NULL
thymic	NULL
stromal	NULL
interactions	NULL
with	NULL
developing	NULL
T	NULL
cells	NULL
leads	NULL
to	NULL
a	NULL
spontaneous	NULL
upregulation	NULL
of	NULL
TCR-af	NULL
complex	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
the	NULL
cells	NULL
together	NULL
with	NULL
dephosphorylation	NULL
of	NULL
the	NULL
CD3F	NULL
chain	NULL
(	NULL
Nakayama	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
thymocytes	NULL
cultured	NULL
in	NULL
suspension	NULL
or	NULL
within	NULL
intact	NULL
lobes	NULL
respond	NULL
differently	NULL
to	NULL
stimulation	NULL
with	NULL
PMA	NULL
,	NULL
mitogen	NULL
Concanavalin	NULL
A	NULL
,	NULL
or	NULL
anti-CD3	NULL
(	NULL
Anderson	NULL
and	NULL
Jenkinson	NULL
,	NULL
1998	NULL
;	NULL
Fisher	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

These	NULL
and	NULL
other	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
interactions	NULL
within	NULL
the	NULL
intact	NULL
thymic	NULL
environment	NULL
play	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
determining	NULL
the	NULL
biological	NULL
outcome	NULL
to	NULL
specific	NULL
stim-uli	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
method	NULL
described	NULL
here	NULL
is	NULL
of	NULL
central	NULL
importance	NULL
,	NULL
as	NULL
it	NULL
provides	NULL
an	NULL
important	NULL
tool	NULL
to	NULL
the	NULL
study	NULL
the	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
development	NULL
by	NULL
enabling	NULL
researchers	NULL
to	NULL
define	NULL
signaling	NULL
mechanisms	NULL
within	NULL
the	NULL
cell	NULL
's	NULL
natural	NULL
environment	NULL
.	NULL

Although	NULL
gene	NULL
gun-mediated	NULL
-	NULL
transfection	NULL
-	NULL
of	NULL
FTOCs	NULL
allows	NULL
thymocytes	NULL
to	NULL
respond	NULL
to	NULL
their	NULL
normal	NULL
environment	NULL
,	NULL
other	NULL
means	NULL
of	NULL
in	NULL
vitro	NULL
gene	NULL
transfer	NULL
also	NULL
confer	NULL
this	NULL
ability	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
retroviral-medi-ated	NULL
infection	NULL
of	NULL
cells	NULL
has	NULL
proven	NULL
to	NULL
be	NULL
a	NULL
viable	NULL
means	NULL
with	NULL
which	NULL
to	NULL
study	NULL
specific	NULL
gene	NULL
function	NULL
during	NULL
thymocyte	NULL
differentiation	NULL
(	NULL
Crompton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Pallard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
;	NULL
Sugawara	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

However	NULL
,	NULL
one	NULL
main	NULL
benefit	NULL
of	NULL
the	NULL
gene-gun	NULL
system	NULL
is	NULL
the	NULL
ability	NULL
to	NULL
transfect	NULL
multiple	NULL
plasmids	NULL
into	NULL
thymocytes	NULL
,	NULL
which	NULL
can	NULL
be	NULL
read	NULL
out	NULL
in	NULL
short	NULL
or	NULL
long	NULL
term	NULL
assays	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
system	NULL
permits	NULL
the	NULL
expression	NULL
of	NULL
specific	NULL
genes	NULL
during	NULL
T	NULL
cell	NULL
development	NULL
,	NULL
together	NULL
with	NULL
the	NULL
use	NULL
of	NULL
a	NULL
separate	NULL
reporter-plasmid	NULL
allowing	NULL
for	NULL
the	NULL
readout	NULL
of	NULL
de	NULL
novo	NULL
signaling	NULL
events	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Animals	NULL
Timed-pregnant	NULL
CD1	NULL
mice	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
Charles	NULL
River	NULL
Laboratories	NULL
(	NULL
St	NULL
.	NULL

Constant	NULL
,	NULL
QC	NULL
Can-ada	NULL
)	NULL
.	NULL

-	NULL
Recombinase	NULL
-	NULL
activating	NULL
-	NULL
gene-2-deficient	NULL
(	NULL
RAG-2/	NULL
~	NULL
)	NULL
mice	NULL
(	NULL
Shinkai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
were	NULL
bred	NULL
and	NULL
maintained	NULL
in	NULL
our	NULL
animal	NULL
facility	NULL
.	NULL

Timed-pregnant	NULL
RAG-2	NULL
``	NULL
mice	NULL
were	NULL
generated	NULL
and	NULL
the	NULL
fetuses	NULL
were	NULL
extracted	NULL
at	NULL
day	NULL
14	NULL
of	NULL
pregnancy	NULL
.	NULL

Electroporation	NULL
of	NULL
ELA	NULL
Cells	NULL
All	NULL
plasmid	NULL
DNA	NULL
used	NULL
for	NULL
transfection	NULL
was	NULL
purified	NULL
by	NULL
anion-exchange	NULL
chromatography	NULL
using	NULL
Qiagen	NULL
columns	NULL
(	NULL
Valencia	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

PathDetect	NULL
reporter-plasmids	NULL
were	NULL
purchased	NULL
from	NULL
Stratagene	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

EL4	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
placed	NULL
in	NULL
RPMI-1640	NULL
DETECTION	NULL
OF	NULL
CELL	NULL
SIGNALS	NULL
IN	NULL
FTOC	NULL
41	NULL
15	NULL
«	NULL
.	NULL

--	NULL
»	NULL
_	NULL
Unstimulated	NULL
|	NULL
--	NULL
@	NULL
-~	NULL
PMA/ionomycin	NULL
<	NULL
10	NULL
7	NULL
&	NULL
<	NULL
.9	NULL
8	NULL
23	NULL
€	NULL
t	NULL
;	NULL
L	NULL
73	NULL
o	NULL
<	NULL
es	NULL
5	NULL
4	NULL
0	NULL
``	NULL
*T	NULL
T	NULL
-r	NULL
Or-	NULL
r	NULL
-r	NULL
-r	NULL
``	NULL
f	NULL
T	NULL
T	NULL
r-r-or-rf	NULL
T4	NULL
Ratio	NULL
(	NULL
pFA-Elk	NULL
:	NULL
pFR-Luc	NULL
)	NULL
FIGURE	NULL
5	NULL
Activation	NULL
of	NULL
MAPK	NULL
signalling	NULL
cascade	NULL
on	NULL
stimulation	NULL
of	NULL
fetal	NULL
thymic	NULL
lobes	NULL
with	NULL
phorbol	NULL
ester	NULL
,	NULL
phorbol-12-myristate-1	NULL
3-acetate	NULL
(	NULL
PMA	NULL
)	NULL
and	NULL
the	NULL
calcium	NULL
ionophore	NULL
,	NULL
ionomycin	NULL
.	NULL

Intact	NULL
fetal	NULL
thymic	NULL
lobes	NULL
removed	NULL
from	NULL
timed-pregnant	NULL
CD1	NULL
mice	NULL
(	NULL
day	NULL
14	NULL
of	NULL
gestation	NULL
)	NULL
,	NULL
were	NULL
used	NULL
as	NULL
targets	NULL
for	NULL
DNA-covered	NULL
gold	NULL
particles	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
of	NULL
fig	NULL
.	NULL

3	NULL
.	NULL

Fetal	NULL
thymuses	NULL
were	NULL
gene	NULL
gun-transfected	NULL
with	NULL
pFR-Luc	NULL
(	NULL
DLR	NULL
=	NULL
250	NULL
ng	NULL
)	NULL
,	NULL
pFA-Elk	NULL
(	NULL
DLR	NULL
=	NULL
25-750	NULL
ng	NULL
)	NULL
,	NULL
and	NULL
CMV-B-gal	NULL
(	NULL
DLR	NULL
=	NULL
250	NULL
ng	NULL
)	NULL
,	NULL
and	NULL
then	NULL
cultured	NULL
for	NULL
12	NULL
to	NULL
18	NULL
hr	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
PMA/ionomycin	NULL
(	NULL
10	NULL
ng/ml	NULL
of	NULL
each	NULL
)	NULL
for	NULL
a	NULL
further	NULL
6	NULL
to	NULL
8	NULL
hr	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
and	NULL
the	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
-galactosidase	NULL
activity	NULL
.	NULL

The	NULL
optimal	NULL
concentration	NULL
of	NULL
pFA-Elk	NULL
in	NULL
fetal	NULL
thymic	NULL
lobes	NULL
is	NULL
250	NULL
ng/shot	NULL
(	NULL
DLR	NULL
=	NULL
250	NULL
ng	NULL
)	NULL
,	NULL
as	NULL
almost	NULL
a	NULL
three	NULL
fold	NULL
stimulation	NULL
is	NULL
observed	NULL
in	NULL
luciferase	NULL
activity	NULL
and	NULL
thus	NULL
MAPK	NULL
activity	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
an	NULL
average	NULL
of	NULL
four	NULL
separate	NULL
experiments	NULL
with	NULL
each	NULL
condition	NULL
carried	NULL
out	NULL
in	NULL
triplicate	NULL
medium	NULL
supplemented	NULL
with	NULL
20	NULL
%	NULL
FCS	NULL
.	NULL

Cells	NULL
were	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
Electro	NULL
Cell	NULL
Manipulator	NULL
600	NULL
apparatus	NULL
transfected	NULL
by	NULL
electroporation	NULL
using	NULL
a	NULL
BTX	NULL
(	NULL
San	NULL
_-	NULL
with	NULL
each	NULL
sample	NULL
containing	NULL
1-3	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
42	NULL
ALISON	NULL
M.	NULL
MICHIE	NULL
and	NULL
JUAN	NULL
CARLOS	NULL
ZUNIGA-PFLUCKER	NULL
cuvette	NULL
(	NULL
4-mm	NULL
gap	NULL
)	NULL
in	NULL
250	NULL
ul	NULL
medium	NULL
.	NULL

Samples	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
with	NULL
21-50	NULL
ug	NULL
plasmid	NULL
DNA	NULL
(	NULL
as	NULL
indicated	NULL
in	NULL
figure	NULL
legends	NULL
)	NULL
and	NULL
then	NULL
elec-troporated	NULL
at	NULL
250	NULL
V	NULL
,	NULL
1200	NULL
uF	NULL
,	NULL
186	NULL
©	NULL
with	NULL
a	NULL
~60	NULL
ms	NULL
time	NULL
constant	NULL
.	NULL

After	NULL
electroporation	NULL
,	NULL
samples	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
then	NULL
cultured	NULL
for	NULL
18	NULL
to	NULL
24	NULL
hr	NULL
in	NULL
DMEM-high	NULL
glucose	NULL
media	NULL
(	NULL
Gibco-BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
10	NULL
U/ml	NULL
penicillin	NULL
,	NULL
100	NULL
ug/ml	NULL
!	NULL

strepto-mycin	NULL
,	NULL
100	NULL
pg/ml	NULL
gentamicin	NULL
,	NULL
110	NULL
ug/ml	NULL
sodium	NULL
pyruvate	NULL
,	NULL
50	NULL
uM	NULL
2-mercaptoethanol	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4	NULL
(	NULL
EL4	NULL
medium	NULL
)	NULL
.	NULL

Phorbol-12-myr-istate-13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
ionomycin	NULL
,	NULL
or	NULL
forskolin	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
as	NULL
described	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Preparation	NULL
of	NULL
DNA/Gold	NULL
Suspension	NULL
The	NULL
DNA/gold	NULL
bound	NULL
cartridges	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
microcarriers	NULL
(	NULL
gold	NULL
powder	NULL
,	NULL
spherical	NULL
(	NULL
1.5	NULL
to	NULL
3.0	NULL
microns	NULL
;	NULL
Aldrich	NULL
Chemical	NULL
Co.	NULL
,	NULL
Milwaukee	NULL
,	NULL
WI	NULL
)	NULL
)	NULL
to	NULL
be	NULL
delivered	NULL
to	NULL
the	NULL
target	NULL
(	NULL
fetal	NULL
thymic	NULL
lobes	NULL
)	NULL
is	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
Microcarrier	NULL
Loading	NULL
Quantity	NULL
(	NULL
MLQ	NULL
)	NULL
.	NULL

Our	NULL
protocol	NULL
is	NULL
optimized	NULL
for	NULL
an	NULL
MLQ	NULL
of	NULL
1	NULL
ug	NULL
of	NULL
gold	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
DNA	NULL
loaded	NULL
per	NULL
microgram	NULL
of	NULL
microcarriers	NULL
is	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
DNA	NULL
Loading	NULL
Ratio	NULL
(	NULL
DLR	NULL
)	NULL
.	NULL

In	NULL
this	NULL
protocol	NULL
,	NULL
the	NULL
DLR	NULL
for	NULL
total	NULL
plasmid	NULL
DNA	NULL
is	NULL
0.65	NULL
:	NULL
1.4	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
,	NULL
as	NULL
the	NULL
MLQ=	NULL
1	NULL
ug	NULL
,	NULL
the	NULL
DLR	NULL
for	NULL
each	NULL
plasmid	NULL
(	NULL
detailed	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
)	NULL
is	NULL
equivalent	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
delivered	NULL
to	NULL
the	NULL
fetal	NULL
thymic	NULL
lobes	NULL
in	NULL
each	NULL
transfection	NULL
.	NULL

To	NULL
prepare	NULL
the	NULL
DNA/gold	NULL
suspension	NULL
,	NULL
100	NULL
ul	NULL
of	NULL
0.05	NULL
M	NULL
spermidine	NULL
was	NULL
added	NULL
to	NULL
40	NULL
ug	NULL
of	NULL
gold	NULL
particles	NULL
.	NULL

This	NULL
solution	NULL
was	NULL
vortexed	NULL
and	NULL
sonicated	NULL
for	NULL
3	NULL
to	NULL
5	NULL
seconds	NULL
to	NULL
remove	NULL
gold	NULL
clumps	NULL
.	NULL

To	NULL
the	NULL
gold/spermidine	NULL
mixture	NULL
,	NULL
DNA	NULL
(	NULL
1	NULL
to	NULL
30	NULL
ug	NULL
of	NULL
each	NULL
plasmid	NULL
)	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
volume	NULL
not	NULL
exceeding	NULL
100	NULL
pul	NULL
,	NULL
and	NULL
vortexed	NULL
.	NULL

While	NULL
vortexing	NULL
,	NULL
the	NULL
DNA	NULL
was	NULL
precipitated	NULL
onto	NULL
gold	NULL
particles	NULL
by	NULL
adding	NULL
100	NULL
ul	NULL
1	NULL
M	NULL
CaCl	NULL
;	NULL
dropwise	NULL
.	NULL

This	NULL
was	NULL
left	NULL
to	NULL
stand	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
(	NULL
RT	NULL
)	NULL
,	NULL
then	NULL
the	NULL
gold/DNA	NULL
bound	NULL
particles	NULL
were	NULL
pelleted	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
removed	NULL
and	NULL
the	NULL
pellet	NULL
was	NULL
washed	NULL
3	NULL
times	NULL
in	NULL
anhydrous	NULL
ethanol	NULL
(	NULL
Aldrich	NULL
Chemical	NULL
Co.	NULL
)	NULL
.	NULL

After	NULL
the	NULL
final	NULL
wash	NULL
,	NULL
the	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
24	NULL
ml	NULL
anhydrous	NULL
ethanol	NULL
containing	NULL
0.1	NULL
%	NULL
polyvi-nylpyrrolidone	NULL
(	NULL
PVP	NULL
;	NULL
Bio-Rad	NULL
Laboratories	NULL
)	NULL
and	NULL
kept	NULL
in	NULL
an	NULL
airtight	NULL
tube	NULL
.	NULL

The	NULL
DNA/gold	NULL
suspension	NULL
is	NULL
ready	NULL
for	NULL
cartridge	NULL
preparation	NULL
,	NULL
however	NULL
it	NULL
can	NULL
be	NULL
stored	NULL
for	NULL
up	NULL
to	NULL
2	NULL
months	NULL
at	NULL
-20°C	NULL
.	NULL

Preparation	NULL
of	NULL
DNA/Gold-Coated	NULL
Cartridges	NULL
In	NULL
order	NULL
to	NULL
generate	NULL
DNA/gold	NULL
bound	NULL
cartridges	NULL
,	NULL
a	NULL
Tubing	NULL
Prep	NULL
Station	NULL
is	NULL
required	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
)	NULL
.	NULL

Immediately	NULL
prior	NULL
to	NULL
preparing	NULL
cartridges	NULL
,	NULL
the	NULL
Gold-Coat	NULL
tubing	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
)	NULL
was	NULL
dried	NULL
by	NULL
purging	NULL
with	NULL
nitrogen	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Seventy-five	NULL
centimeters	NULL
of	NULL
dried	NULL
tubing	NULL
was	NULL
then	NULL
placed	NULL
in	NULL
the	NULL
Tubing	NULL
Prep	NULL
Station	NULL
.	NULL

The	NULL
DNA/gold	NULL
particle	NULL
suspension	NULL
was	NULL
vortexed	NULL
,	NULL
then	NULL
drawn	NULL
into	NULL
a	NULL
syringe	NULL
and	NULL
injected	NULL
into	NULL
the	NULL
dried	NULL
tubing	NULL
.	NULL

The	NULL
microcarriers	NULL
were	NULL
allowed	NULL
to	NULL
settle	NULL
for	NULL
3	NULL
to	NULL
5	NULL
min	NULL
then	NULL
the	NULL
ethanol/PVP	NULL
solution	NULL
was	NULL
slowly	NULL
drawn	NULL
back	NULL
into	NULL
the	NULL
syringe	NULL
,	NULL
leaving	NULL
the	NULL
DNA-bound	NULL
gold	NULL
in	NULL
the	NULL
tubing	NULL
.	NULL

The	NULL
syringe	NULL
was	NULL
removed	NULL
and	NULL
the	NULL
Gold-Coat	NULL
tubing	NULL
was	NULL
immediately	NULL
turned	NULL
180°	NULL
to	NULL
allow	NULL
the	NULL
gold	NULL
to	NULL
coat	NULL
the	NULL
inside	NULL
of	NULL
the	NULL
tubing	NULL
.	NULL

After	NULL
10	NULL
seconds	NULL
,	NULL
the	NULL
tubing	NULL
is	NULL
rotated	NULL
for	NULL
3	NULL
to	NULL
5	NULL
min	NULL
,	NULL
thus	NULL
coating	NULL
the	NULL
tube	NULL
with	NULL
gold/DNA	NULL
particles	NULL
.	NULL

Following	NULL
the	NULL
tube	NULL
coating	NULL
with	NULL
the	NULL
DNA/gold	NULL
,	NULL
the	NULL
tubing	NULL
was	NULL
dried	NULL
by	NULL
passing	NULL
nitrogen	NULL
for	NULL
3	NULL
min	NULL
.	NULL

The	NULL
DNA/gold-coated	NULL
tube	NULL
was	NULL
removed	NULL
from	NULL
the	NULL
Tubing	NULL
Prep	NULL
Station	NULL
,	NULL
and	NULL
cut	NULL
into	NULL
1.25	NULL
,	NULL
cm	NULL
cartridges	NULL
using	NULL
a	NULL
Tubing	NULL
Cutter	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
)	NULL
.	NULL

The	NULL
DNA/gold	NULL
slurry	NULL
(	NULL
2.4	NULL
ml	NULL
)	NULL
generates	NULL
40	NULL
cartridges	NULL
with	NULL
the	NULL
desired	NULL
MLQ	NULL
.	NULL

The	NULL
prepared	NULL
cartridges	NULL
can	NULL
be	NULL
stored	NULL
at	NULL
4°C	NULL
for	NULL
up	NULL
to	NULL
8	NULL
months	NULL
.	NULL

Transfection	NULL
of	NULL
Fetal	NULL
Thymuses	NULL
Fetal	NULL
thymuses	NULL
isolated	NULL
from	NULL
gestational	NULL
day	NULL
13-14	NULL
time-pregnant	NULL
mice	NULL
were	NULL
placed	NULL
on	NULL
prewetted	NULL
Nucleopore	NULL
filters	NULL
(	NULL
13	NULL
mm	NULL
,	NULL
0.8	NULL
um	NULL
pore	NULL
size	NULL
,	NULL
polycar-bonate	NULL
)	NULL
(	NULL
Corning	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
4	NULL
to	NULL
6	NULL
lobes	NULL
per	NULL
filter	NULL
in	NULL
FTOC	NULL
media	NULL
(	NULL
EL4	NULL
media	NULL
supplemented	NULL
with	NULL
a	NULL
further	NULL
5	NULL
%	NULL
FCS	NULL
)	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
placed	NULL
on	NULL
top	NULL
of	NULL
media-soaked	NULL
Gelfoam	NULL
(	NULL
Upjohn	NULL
Canada	NULL
,	NULL
Don	NULL
Mills	NULL
,	NULL
ON	NULL
)	NULL
rafts	NULL
.	NULL

DETECTION	NULL
OF	NULL
CELL	NULL
SIGNALS	NULL
IN	NULL
FTOC	NULL
43	NULL
5	NULL
=	NULL
«	NULL
«	NULL
«	NULL
-	NULL
@	NULL
-	NULL
»	NULL
+-	NULL
_	NULL
Unstimulated	NULL
-	NULL
--	NULL
&	NULL
@	NULL
--	NULL
_	NULL
FOorskOlin	NULL
4	NULL
[	NULL
=	NULL
3	NULL
.J	NULL
.3	NULL
A3	NULL
.E	NULL
|	NULL
brs	NULL
``	NULL
3	NULL
+4	NULL
U	NULL
1	NULL
J-	NULL
T	NULL
.g-.ll.l-II'-.o	NULL
l	NULL
``	NULL
I	NULL
0	NULL
--	NULL
-	NULL
...	NULL
.	NULL

,	NULL
._	NULL
``	NULL
_0__	NULL
,	NULL
.	NULL

--	NULL
..-	NULL
J.	NULL
L	NULL
0	NULL
~	NULL
``	NULL
u	NULL
-r	NULL
~~~	NULL
~I	NULL
0.1	NULL
1	NULL
10	NULL
Ratio	NULL
(	NULL
pFA2-CREB	NULL
:	NULL
pFR-Luc	NULL
)	NULL
FIGURE	NULL
6	NULL
Activation	NULL
of	NULL
PKA	NULL
signaling	NULL
cascade	NULL
on	NULL
stimulation	NULL
of	NULL
fetal	NULL
thymic	NULL
lobes	NULL
with	NULL
the	NULL
adenylyl	NULL
cyclase	NULL
activator	NULL
,	NULL
forskolin	NULL
.	NULL

Intact	NULL
fetal	NULL
thymic	NULL
lobes	NULL
removed	NULL
from	NULL
timed-pregnant	NULL
CD1	NULL
mice	NULL
(	NULL
day	NULL
14	NULL
of	NULL
gestation	NULL
)	NULL
were	NULL
used	NULL
as	NULL
targets	NULL
for	NULL
DNA-covered	NULL
gold	NULL
particles	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
of	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Fetal	NULL
thymuses	NULL
were	NULL
gene	NULL
gun-transfected	NULL
with	NULL
pFR-Luc	NULL
(	NULL
DLR	NULL
=	NULL
250	NULL
ng	NULL
)	NULL
,	NULL
pFA-CREB	NULL
(	NULL
DLR	NULL
=	NULL
25-750	NULL
ng	NULL
)	NULL
,	NULL
and	NULL
CMV-B-gal	NULL
(	NULL
DLR	NULL
=	NULL
250	NULL
ng	NULL
)	NULL
,	NULL
and	NULL
then	NULL
cultured	NULL
for	NULL
12	NULL
to	NULL
18	NULL
hr	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
forskolin	NULL
(	NULL
20	NULL
ug/m	NULL
!	NULL

1	NULL
)	NULL
for	NULL
a	NULL
further	NULL
6	NULL
to	NULL
8	NULL
hr	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
and	NULL
the	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

The	NULL
optimal	NULL
concentration	NULL
of	NULL
pFAZ-CREB-activator	NULL
in	NULL
fetal	NULL
thymic	NULL
lobes	NULL
is	NULL
75	NULL
ng/shot	NULL
(	NULL
DLR	NULL
=	NULL
75	NULL
ng	NULL
)	NULL
,	NULL
as	NULL
>	NULL
four	NULL
fold	NULL
stimulation	NULL
is	NULL
seen	NULL
in	NULL
luciferase	NULL
activity	NULL
and	NULL
thus	NULL
PKA	NULL
activity	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
an	NULL
average	NULL
of	NULL
six	NULL
separate	NULL
experiments	NULL
with	NULL
each	NULL
condition	NULL
carried	NULL
out	NULL
in	NULL
triplicate	NULL
After	NULL
6	NULL
hr	NULL
,	NULL
the	NULL
filters	NULL
carrying	NULL
the	NULL
fetal	NULL
thymic	NULL
lobes	NULL
diately	NULL
transfected	NULL
by	NULL
gene	NULL
gun-bombardment	NULL
with	NULL
a	NULL
were	NULL
transferred	NULL
onto	NULL
a	NULL
petri	NULL
dish	NULL
(	NULL
6	NULL
mm	NULL
)	NULL
,	NULL
and	NULL
imme-	NULL
__	NULL
Helios	NULL
Gene	NULL
gun	NULL
set	NULL
at	NULL
200	NULL
psi	NULL
(	NULL
Bio-Rad	NULL
Laborato-	NULL
44	NULL
ALISON	NULL
M.	NULL
MICHIE	NULL
and	NULL
JUAN	NULL
CARLOS	NULL
ZUNIGA-PFLUCKER	NULL
ries	NULL
)	NULL
,	NULL
using	NULL
one	NULL
cartridge	NULL
per	NULL
set	NULL
of	NULL
lobes	NULL
.	NULL

The	NULL
filters	NULL
carrying	NULL
the	NULL
transfected	NULL
fetal	NULL
lobes	NULL
were	NULL
then	NULL
placed	NULL
back	NULL
onto	NULL
the	NULL
Gelfoam	NULL
rafts	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
8-24	NULL
hr	NULL
in	NULL
a	NULL
humidified	NULL
incubator	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
transfected	NULL
lobes	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
to	NULL
6	NULL
hr	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
pharmacological	NULL
reagents	NULL
as	NULL
stated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Thereafter	NULL
,	NULL
the	NULL
lobes	NULL
were	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
12	NULL
to	NULL
18	NULL
hr	NULL
prior	NULL
to	NULL
analysis	NULL
.	NULL

For	NULL
long-term	NULL
developmental	NULL
progression	NULL
analysis	NULL
,	NULL
transfected	NULL
fetal	NULL
thymic	NULL
lobes	NULL
were	NULL
incubated	NULL
for	NULL
9	NULL
days	NULL
,	NULL
changing	NULL
FTOC	NULL
media	NULL
once	NULL
during	NULL
the	NULL
incubation	NULL
.	NULL

Luciferase	NULL
and	NULL
B-Galactosidase	NULL
Assay	NULL
A	NULL
single-cell	NULL
suspension	NULL
was	NULL
prepared	NULL
in	NULL
phos-phate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
;	NULL
Gibco-BRL	NULL
)	NULL
from	NULL
transfected	NULL
thymic	NULL
lobes	NULL
by	NULL
crushing	NULL
the	NULL
lobes	NULL
through	NULL
a	NULL
prewetted	NULL
70	NULL
um	NULL
nylon	NULL
mesh	NULL
filter	NULL
(	NULL
BioDesign	NULL
,	NULL
Car-mel	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
using	NULL
the	NULL
Dual-Light	NULL
reporter	NULL
gene	NULL
assay	NULL
-	NULL
system	NULL
-	NULL
(	NULL
Tropix	NULL
,	NULL
-	NULL
Perkin	NULL
Elmer-Applied	NULL
Biosystems	NULL
,	NULL
Norwalk	NULL
,	NULL
CT	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
thymocytes	NULL
were	NULL
lysed	NULL
in	NULL
25	NULL
ul	NULL
Lysis	NULL
Buffer	NULL
(	NULL
40	NULL
mM	NULL
Tricine	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
MgSQO4	NULL
,	NULL
5	NULL
mM	NULL
dithiothrietol	NULL
(	NULL
DTT	NULL
)	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X100	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
RT	NULL
,	NULL
and	NULL
then	NULL
centrifuged	NULL
(	NULL
13,000	NULL
g	NULL
)	NULL
for	NULL
5	NULL
min	NULL
to	NULL
remove	NULL
cell	NULL
debris	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
combined	NULL
with	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
Luciferase	NULL
Reaction	NULL
Buffer	NULL
(	NULL
30	NULL
mM	NULL
Tricine	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
3	NULL
mM	NULL
ATP	NULL
,	NULL
15	NULL
mM	NULL
MgSQ4	NULL
,	NULL
1	NULL
mM	NULL
Coenzyme	NULL
A	NULL
,	NULL
10	NULL
mM	NULL
DTT	NULL
)	NULL
,	NULL
and	NULL
after	NULL
addition	NULL
of	NULL
1	NULL
mM	NULL
luciferin	NULL
(	NULL
100	NULL
ul	NULL
)	NULL
the	NULL
sample	NULL
was	NULL
immediately	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
,	NULL
with	NULL
a	NULL
Lumat	NULL
LB	NULL
9507	NULL
Luminometer	NULL
(	NULL
Fischer	NULL
Scientific	NULL
Canada	NULL
,	NULL
Unionville	NULL
,	NULL
ON	NULL
)	NULL
,	NULL
with	NULL
light	NULL
emission	NULL
read	NULL
out	NULL
for	NULL
10	NULL
seconds	NULL
.	NULL

To	NULL
assay	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
,	NULL
Galacton-Plus	NULL
(	NULL
substrate	NULL
for	NULL
B-galactosidase	NULL
;	NULL
Tropix	NULL
)	NULL
was	NULL
added	NULL
to	NULL
each	NULL
tube	NULL
after	NULL
the	NULL
luciferase	NULL
assay	NULL
was	NULL
completed	NULL
.	NULL

The	NULL
tubes	NULL
were	NULL
incubated	NULL
at	NULL
RT	NULL
for	NULL
30	NULL
to	NULL
60	NULL
min	NULL
,	NULL
then	NULL
Accelerator-II	NULL
(	NULL
100	NULL
ul	NULL
;	NULL
Tropix	NULL
)	NULL
was	NULL
added	NULL
to	NULL
each	NULL
tube	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
immediately	NULL
assayed	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
,	NULL
measured	NULL
as	NULL
light	NULL
emission	NULL
with	NULL
a	NULL
Lumat	NULL
LB	NULL
9507	NULL
Luminometer	NULL
,	NULL
with	NULL
light	NULL
emission	NULL
read	NULL
out	NULL
for	NULL
10	NULL
seconds	NULL
.	NULL

Results	NULL
shown	NULL
represent	NULL
the	NULL
averages	NULL
of	NULL
assays	NULL
carried	NULL
out	NULL
in	NULL
triplicate	NULL
.	NULL

Flow	NULL
Cytometric	NULL
Analysis	NULL
Transfected	NULL
fetal	NULL
thymic	NULL
lobes	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
the	NULL
desired	NULL
time	NULL
(	NULL
as	NULL
described	NULL
in	NULL
figure	NULL
legends	NULL
)	NULL
,	NULL
then	NULL
single-cell	NULL
suspensions	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
anti-mouse	NULL
antibodies	NULL
in	NULL
FACS	NULL
buffer	NULL
(	NULL
Hank	NULL
's	NULL
balanced	NULL
salt	NULL
solution	NULL
(	NULL
without	NULL
phenol	NULL
red	NULL
)	NULL
containing	NULL
1	NULL
%	NULL
BSA	NULL
and	NULL
0.05	NULL
%	NULL
NaN	NULL
;	NULL
)	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
antibodies	NULL
used	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
FITC-conjugated	NULL
CD25	NULL
(	NULL
7D4	NULL
)	NULL
;	NULL
R-PE-conjugated	NULL
CD8a	NULL
(	NULL
53-6.7	NULL
)	NULL
;	NULL
APC-conjugated	NULL
CD4	NULL
(	NULL
RM4-5	NULL
)	NULL
,	NULL
or	NULL
biotinylated	NULL
CD45	NULL
(	NULL
30F11.1	NULL
)	NULL
purchased	NULL
from	NULL
Pharmingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
stained	NULL
thymocytes	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
in	NULL
FACS	NULL
buffer	NULL
and	NULL
,	NULL
where	NULL
biotinylated	NULL
antibodies	NULL
were	NULL
used	NULL
,	NULL
incubated	NULL
for	NULL
a	NULL
further	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Strepta-vidin-APC	NULL
(	NULL
Pharmingen	NULL
)	NULL
.	NULL

Stained	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
FACS	NULL
buffer	NULL
and	NULL
analyzed	NULL
with	NULL
a	NULL
FACSCal-iber	NULL
flow	NULL
cytometer	NULL
using	NULL
CELLQuest	NULL
software	NULL
(	NULL
Bec-ton-Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
;	NULL
data	NULL
was	NULL
live-gated	NULL
by	NULL
size	NULL
and	NULL
lack	NULL
of	NULL
propidium	NULL
iodide	NULL
uptake	NULL
.	NULL

Acknowledgements	NULL
We	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Dr.	NULL
Pamela	NULL
Ohashi	NULL
for	NULL
the	NULL
plasmid	NULL
encoding	NULL
constitutively	NULL
active	NULL
Ras	NULL
.	NULL

A.	NULL
M.	NULL
Michie	NULL
is	NULL
supported	NULL
by	NULL
a	NULL
postdoctoral	NULL
fellowship	NULL
from	NULL
the	NULL
Cancer	NULL
Research	NULL
Institute	NULL
.	NULL

J.	NULL
C.	NULL
Zuniga-Pfliicker	NULL
is	NULL
supported	NULL
by	NULL
a	NULL
scholarship	NULL
from	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
Canada	NULL
.	NULL

This	NULL
work	NULL
is	NULL
funded	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Leukemia	NULL
Research	NULL
Fund	NULL
of	NULL
Canada	NULL
.	NULL

References	NULL
Anderson	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Jenkinson	NULL
,	NULL
E.J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Use	NULL
of	NULL
Explant	NULL
Technology	NULL
in	NULL
the	NULL
Study	NULL
of	NULL
In	NULL
Vitro	NULL
Immune	NULL
Responses	NULL
.	NULL

J.	NULL
Immu-nolog	NULL
.	NULL

Methods	NULL
216	NULL
;	NULL
155-163	NULL
.	NULL

Anderson	NULL
,	NULL
G.	NULL
,	NULL
Moore	NULL
,	NULL
N.C.	NULL
,	NULL
Owen	NULL
,	NULL
J.J.	NULL
,	NULL
and	NULL
Jenkinson	NULL
,	NULL
E.J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Cellular	NULL
interactions	NULL
in	NULL
thymocyte	NULL
development	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

74	NULL
;	NULL
73-99	NULL
.	NULL

Clements	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Yang	NULL
,	NULL
B.	NULL
,	NULL
Ross-Barta	NULL
;	NULL
S.	NULL
E.	NULL
,	NULL
Eliason	NULL
,	NULL
RF	NULL
.	NULL

,	NULL
William-son	NULL
,	NULL
R.A.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Requirement	NULL
for	NULL
the	NULL
Leukocyte-Specific	NULL
Adapter	NULL
Protein	NULL
SLP-76	NULL
for	NULL
normal	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Science	NULL
281	NULL
:	NULL
416-419	NULL
.	NULL

Crompton	NULL
,	NULL
T.	NULL
,	NULL
Gilmour	NULL
,	NULL
K.C	NULL
.	NULL

,	NULL
and	NULL
Owen	NULL
,	NULL
M.J.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
MAP	NULL
kinase	NULL
pathway	NULL
controls	NULL
differentiation	NULL
from	NULL
double-negative	NULL
to	NULL
double	NULL
positive	NULL
thymocyte	NULL
.	NULL

Cell	NULL
86	NULL
:	NULL
243-251	NULL
.	NULL

Downward	NULL
,	NULL
J.	NULL
,	NULL
de	NULL
Gunzburg	NULL
,	NULL
J.	NULL
,	NULL
Rich	NULL
]	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Weinberg	NULL
,	NULL
R.A.	NULL
(	NULL
1988	NULL
)	NULL
.	NULL

p21ras-induced	NULL
responsiveness	NULL
of	NULL
phosphatidylinosi-	NULL
DETECTION	NULL
OF	NULL
CELL	NULL
SIGNALS	NULL
IN	NULL
FTOC	NULL
45	NULL
tol	NULL
turnover	NULL
to	NULL
bradykinin	NULL
is	NULL
a	NULL
receptor	NULL
number	NULL
effect	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
:	NULL
5774-5778	NULL
.	NULL

Fisher	NULL
,	NULL
G.H	NULL
.	NULL

,	NULL
Lenardo	NULL
,	NULL
M.J.	NULL
,	NULL
and	NULL
Zdfiga-Pfliicker	NULL
,	NULL
J.C.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Synergy	NULL
between	NULL
T	NULL
cell	NULL
receptor	NULL
and	NULL
Fas	NULL
(	NULL
CD95/APO-1	NULL
)	NULL
signalling	NULL
in	NULL
mouse	NULL
thymocyte	NULL
death	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

769	NULL
;	NULL
99-106	NULL
.	NULL

Fowlkes	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
and	NULL
Schweighoffer	NULL
,	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Positive	NULL
selection	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
,	NULL
188-195	NULL
.	NULL

Galandrini	NULL
,	NULL
R.	NULL
,	NULL
Henning	NULL
,	NULL
S.W	NULL
.	NULL

,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Different	NULL
Functions	NULL
of	NULL
the	NULL
GTPase	NULL
Rho	NULL
in	NULL
Prothymocytes	NULL
and	NULL
Late	NULL
Pre-T	NULL
cells	NULL
.	NULL

Immunity	NULL
7	NULL
;	NULL
163-174	NULL
.	NULL

Godfrey	NULL
,	NULL
D.L	NULL
,	NULL
Kennedy	NULL
,	NULL
J.	NULL
,	NULL
Suda	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Zlotnik	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

A	NULL
developmental	NULL
pathway	NULL
involving	NULL
four	NULL
phenotypically	NULL
and	NULL
functionally	NULL
distinct	NULL
subsets	NULL
of	NULL
CD3	NULL
CD4	NULL
CD8	NULL
``	NULL
triple	NULL
negative	NULL
adult	NULL
mouse	NULL
thymocytes	NULL
defined	NULL
by	NULL
CD44	NULL
and	NULL
CD25	NULL
expres-sion	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150	NULL
;	NULL
4244-4252	NULL
.	NULL

Godfrey	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
and	NULL
Zlotnik	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Control	NULL
points	NULL
in	NULL
early	NULL
T-cell	NULL
development	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
14	NULL
;	NULL
547-553	NULL
.	NULL

Hoffman	NULL
,	NULL
E.S	NULL
.	NULL

,	NULL
Passoni	NULL
,	NULL
L.	NULL
,	NULL
Crompton	NULL
,	NULL
T.	NULL
,	NULL
Leu	NULL
,	NULL
T.M.J	NULL
.	NULL

,	NULL
Schatz	NULL
,	NULL
D.G	NULL
.	NULL

,	NULL
Koff	NULL
,	NULL
A.	NULL
,	NULL
Owen	NULL
,	NULL
M.J.	NULL
,	NULL
and	NULL
Hayday	NULL
,	NULL
A.C.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Productive	NULL
T-cell	NULL
receptor	NULL
B-chain	NULL
gene	NULL
rearrangement	NULL
:	NULL
coincident	NULL
regulation	NULL
of	NULL
cell	NULL
cycle	NULL
and	NULL
clonality	NULL
during	NULL
development	NULL
in	NULL
vivo	NULL
.	NULL

Genes	NULL
and	NULL
Dev	NULL
.	NULL

10	NULL
;	NULL
948-962	NULL
.	NULL

Jenkinson	NULL
,	NULL
E.J	NULL
.	NULL

,	NULL
Franchi	NULL
,	NULL
L.	NULL
,	NULL
Kingston	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Owen	NULL
,	NULL
J.J.T	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
deoxyguanosine	NULL
on	NULL
lymphopoicesis	NULL
in	NULL
the	NULL
developing	NULL
thymus	NULL
rudiment	NULL
in	NULL
vitro	NULL
:	NULL
application	NULL
in	NULL
the	NULL
production	NULL
of	NULL
chimeric	NULL
thymus	NULL
rudiments	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

72	NULL
,	NULL
583	NULL
.	NULL

Kisiclow	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
von	NULL
Boehmer	NULL
,	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Negative	NULL
and	NULL
positive	NULL
selection	NULL
on	NULL
immature	NULL
thymocytes	NULL
:	NULL
timing	NULL
and	NULL
the	NULL
role	NULL
of	NULL
lig-and	NULL
for	NULL
o/B	NULL
T	NULL
cell	NULL
receptor	NULL
.	NULL

Semm	NULL
.	NULL

Immunol	NULL
.	NULL

2	NULL
;	NULL
35-44	NULL
.	NULL

Levin	NULL
,	NULL
S.D	NULL
.	NULL

,	NULL
Anderson	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
Forbush	NULL
,	NULL
K.A	NULL
.	NULL

,	NULL
and	NULL
Perlmutter	NULL
,	NULL
R.M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

A	NULL
dominant-negative	NULL
transgene	NULL
defines	NULL
a	NULL
role	NULL
for	NULL
p56	NULL
``	NULL
in	NULL
thymopoiesis	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

72	NULL
;	NULL
1671-1680	NULL
.	NULL

Michie	NULL
,	NULL
A.M.	NULL
,	NULL
and	NULL
Zdfiga-Pfliicker	NULL
,	NULL
J.C.	NULL
(	NULL
2000	NULL
)	NULL
.	NULL

Transfection	NULL
and	NULL
Transcription	NULL
of	NULL
Genes	NULL
in	NULL
Developing	NULL
Thymocytes	NULL
.	NULL

In	NULL
Methods	NULL
in	NULL
Molecular	NULL
Biology	NULL
:	NULL
Protocols	NULL
in	NULL
T	NULL
cell	NULL
Development	NULL
and	NULL
Activation	NULL
,	NULL
K.P	NULL
.	NULL

Kearse	NULL
,	NULL
ed	NULL
.	NULL

(	NULL
Totawa	NULL
,	NULL
NJ	NULL
:	NULL
Humana	NULL
Press	NULL
)	NULL
,	NULL
134	NULL
;	NULL
55-62	NULL
.	NULL

Molina	NULL
,	NULL
T.J.	NULL
,	NULL
Kishihara	NULL
,	NULL
K.	NULL
,	NULL
Siderovski	NULL
,	NULL
D.P	NULL
.	NULL

,	NULL
van	NULL
Ewijk	NULL
,	NULL
W.	NULL
,	NULL
Nav-endran	NULL
,	NULL
A.W	NULL
.	NULL

,	NULL
Timms	NULL
,	NULL
E.	NULL
,	NULL
Wakeham	NULL
,	NULL
A.	NULL
,	NULL
Paige	NULL
,	NULL
C.J	NULL
.	NULL

,	NULL
Hart-mann	NULL
,	NULL
K.U	NULL
.	NULL

,	NULL
Veillette	NULL
,	NULL
A.	NULL
,	NULL
Davidson	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Mak	NULL
,	NULL
T.W	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Profound	NULL
block	NULL
in	NULL
thymocyte	NULL
development	NULL
in	NULL
mice	NULL
lacking	NULL
p56	NULL
``	NULL
.	NULL

Nature	NULL
357	NULL
;	NULL
161-164	NULL
.	NULL

Nakayama	NULL
,	NULL
T.	NULL
,	NULL
June	NULL
,	NULL
CH	NULL
.	NULL

,	NULL
Munitz	NULL
,	NULL
T.L	NULL
,	NULL
Sheard	NULL
,	NULL
M.	NULL
,	NULL
McCarthy	NULL
,	NULL
S.A.	NULL
,	NULL
Sharrow	NULL
,	NULL
$	NULL
.0.	NULL
,	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
and	NULL
Singer	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
expression	NULL
and	NULL
function	NULL
in	NULL
mature	NULL
CD4+	NULL
CD8+	NULL
cells	NULL
by	NULL
CD4	NULL
.	NULL

Science	NULL
249	NULL
;	NULL
1558	NULL
.	NULL

Negishi	NULL
,	NULL
I.	NULL
,	NULL
Motoyama	NULL
,	NULL
N.	NULL
,	NULL
Nakayama	NULL
,	NULL
K.	NULL
,	NULL
Senju	NULL
,	NULL
S.	NULL
,	NULL
Hatakeyama	NULL
,	NULL
S.	NULL
,	NULL
Zhang	NULL
,	NULL
Q.	NULL
,	NULL
Chan	NULL
,	NULL
A.C.	NULL
,	NULL
and	NULL
Loh	NULL
,	NULL
D.Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Essential	NULL
role	NULL
for	NULL
ZAP-70	NULL
in	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
selection	NULL
of	NULL
thymocytes	NULL
.	NULL

Nature	NULL
376	NULL
;	NULL
435-438	NULL
.	NULL

Nickoloff	NULL
,	NULL
J.A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Animal	NULL
cell	NULL
electroporation	NULL
and	NULL
electrofu-sion	NULL
Protocols	NULL
.	NULL

In	NULL
Methods	NULL
in	NULL
Molecular	NULL
Biology	NULL
,	NULL
J.A	NULL
.	NULL

Nickoloff	NULL
,	NULL
ed	NULL
.	NULL

(	NULL
Totowa	NULL
,	NULL
NJ	NULL
:	NULL
Humana	NULL
Press	NULL
)	NULL
48	NULL
;	NULL
115-121	NULL
.	NULL

Pallard	NULL
C.	NULL
,	NULL
Stegmann	NULL
,	NULL
A	NULL
P.	NULL
,	NULL
van	NULL
Kleffens	NULL
,	NULL
T.	NULL
,	NULL
Smart	NULL
;	NULL
F.	NULL
,	NULL
Venkitara-man	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Spits	NULL
,	NULL
H.	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Distinct	NULL
roles	NULL
of	NULL
the	NULL
phosphati-dylinositol	NULL
3-kinase	NULL
and	NULL
STATS	NULL
pathways	NULL
in	NULL
IL-7-mediated	NULL
development	NULL
of	NULL
human	NULL
thymocyte	NULL
precursors	NULL
.	NULL

Immunity	NULL
10	NULL
;	NULL
525-535	NULL
.	NULL

Rooke	NULL
,	NULL
R.	NULL
,	NULL
Waltzinger	NULL
,	NULL
C.	NULL
,	NULL
Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mathi	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Targeted	NULL
complementation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
deficiency	NULL
by	NULL
intrath-ymic	NULL
delivery	NULL
of	NULL
recombinant	NULL
adenoviruses	NULL
.	NULL

Immunity	NULL
7	NULL
;	NULL
123-134	NULL
.	NULL

Shinkai	NULL
,	NULL
Y.	NULL
,	NULL
Rathbun	NULL
,	NULL
G.	NULL
,	NULL
Lam	NULL
,	NULL
K.-P.	NULL
,	NULL
Oltz	NULL
,	NULL
E.M.	NULL
,	NULL
Stewart	NULL
,	NULL
V.	NULL
,	NULL
Men-delsohn	NULL
,	NULL
M.	NULL
,	NULL
Charron	NULL
,	NULL
J.	NULL
,	NULL
Datta	NULL
,	NULL
M.	NULL
,	NULL
Young	NULL
,	NULL
F.	NULL
,	NULL
Stall	NULL
,	NULL
A.M.	NULL
,	NULL
and	NULL
Alt	NULL
,	NULL
EW	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

RAG-2-deficient	NULL
mice	NULL
lack	NULL
mature	NULL
lym-phocytes	NULL
owing	NULL
to	NULL
inability	NULL
to	NULL
initiate	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
rearrangement	NULL
.	NULL

Cell	NULL
68	NULL
;	NULL
855-867	NULL
.	NULL

Shortman	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Wu	NULL
,	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Early	NULL
T	NULL
lymphocyte	NULL
progenitors	NULL
.	NULL

Ann	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14	NULL
;	NULL
29-47	NULL
.	NULL

Sugawara	NULL
,	NULL
T.	NULL
,	NULL
Di	NULL
Bartolo	NULL
,	NULL
V.	NULL
,	NULL
Miyazaki	NULL
,	NULL
T.	NULL
,	NULL
Nakauchi	NULL
,	NULL
H.	NULL
,	NULL
Acuto	NULL
,	NULL
O.	NULL
,	NULL
and	NULL
Takahama	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

An	NULL
improved	NULL
retroviral	NULL
gene	NULL
transfer	NULL
technique	NULL
demonstrates	NULL
inhibition	NULL
of	NULL
CD4-CD§8-thy-mocyte	NULL
development	NULL
by	NULL
kinase-inactive	NULL
ZAP-70	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161	NULL
;	NULL
2888-2894	NULL
.	NULL

Suzuki	NULL
,	NULL
H.	NULL
,	NULL
Zelphati	NULL
,	NULL
O.	NULL
,	NULL
Hildebrand	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Leserman	NULL
,	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

CD4	NULL
and	NULL
CD7	NULL
molecules	NULL
as	NULL
targets	NULL
for	NULL
drug	NULL
delivery	NULL
from	NULL
antibody	NULL
bearing	NULL
liposomes	NULL
.	NULL

Exp	NULL
.	NULL

Cell	NULL
.	NULL

Res	NULL
.	NULL

193	NULL
;	NULL
112-119	NULL
.	NULL

Swan	NULL
,	NULL
K.A	NULL
.	NULL

,	NULL
Alberola-la	NULL
,	NULL
J.	NULL
,	NULL
Gross	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Appleby	NULL
,	NULL
M.W	NULL
.	NULL

,	NULL
Forbush	NULL
,	NULL
K.A	NULL
.	NULL

,	NULL
Thomas	NULL
,	NULL
J.F	NULL
.	NULL

,	NULL
and	NULL
Perlmutter	NULL
,	NULL
R.M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Involvement	NULL
of	NULL
p21ras	NULL
distinguishes	NULL
positive	NULL
and	NULL
negative	NULL
selection	NULL
in	NULL
thymocytes	NULL
.	NULL

EMBO	NULL
J	NULL
14	NULL
;	NULL
276-285	NULL
.	NULL

Swat	NULL
,	NULL
W.	NULL
,	NULL
Shinkai	NULL
,	NULL
Y.	NULL
,	NULL
Cheng	NULL
,	NULL
HL	NULL
.	NULL

,	NULL
Davidson	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Alt	NULL
,	NULL
EW	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Activated	NULL
ras	NULL
signals	NULL
differentiation	NULL
and	NULL
expansion	NULL
of	NULL
CD4+CD8+	NULL
thymocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
;	NULL
4683-4687.	NULL
von	NULL
Boehmer	NULL
,	NULL
H.	NULL
,	NULL
Aifantis	NULL
,	NULL
I.	NULL
,	NULL
Feinberg	NULL
,	NULL
J.	NULL
,	NULL
Lechner	NULL
,	NULL
O.	NULL
,	NULL
Saint-Ruf	NULL
,	NULL
C.	NULL
,	NULL
Walter	NULL
,	NULL
U.	NULL
,	NULL
Buer	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Azogui	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

Pleiotropic	NULL
changes	NULL
controlled	NULL
by	NULL
the	NULL
pre-T-cell	NULL
receptor	NULL
,	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

77	NULL
;	NULL
135-142.	NULL
von	NULL
Boehmer	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Fehling	NULL
;	NULL
H.J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
the	NULL
pre-T	NULL
cell	NULL
receptor	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15	NULL
;	NULL
433-452	NULL
.	NULL

Zhang	NULL
,	NULL
W.	NULL
,	NULL
Sommers	NULL
,	NULL
C.L	NULL
.	NULL

,	NULL
Burshtyn	NULL
,	NULL
D.N	NULL
.	NULL

,	NULL
Stebbins	NULL
,	NULL
C.C	NULL
.	NULL

,	NULL
DeJar-nette	NULL
,	NULL
J.B.	NULL
,	NULL
Trible	NULL
,	NULL
RP	NULL
.	NULL

,	NULL
Grinberg	NULL
,	NULL
A.	NULL
,	NULL
Tsay	NULL
,	NULL
H.C.	NULL
,	NULL
Jacobs	NULL
,	NULL
H.M.	NULL
,	NULL
Kessler	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
Long	NULL
,	NULL
E.0	NULL
.	NULL

,	NULL
Love	NULL
,	NULL
P.E	NULL
.	NULL

,	NULL
and	NULL
Samelson	NULL
,	NULL
L.	NULL
E	NULL
,	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Essential	NULL
role	NULL
of	NULL
LAT	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Immunity	NULL
10	NULL
;	NULL
323-332	NULL
.	NULL

Zaniga-Pfliicker	NULL
,	NULL
J.C.	NULL
,	NULL
and	NULL
Lenardo	NULL
,	NULL
M.J.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
thymocyte	NULL
development	NULL
from	NULL
immature	NULL
progenitors	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
;	NULL
215-224	NULL
.	NULL

Zuniga-Pfliicker	NULL
,	NULL
J.C.	NULL
,	NULL
Schwartz	NULL
,	NULL
HL	NULL
.	NULL

,	NULL
and	NULL
Lenardo	NULL
,	NULL
M.J.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Gene	NULL
transcription	NULL
in	NULL
differentiating	NULL
immature	NULL
T	NULL
cell	NULL
recep-tor	NULL
``	NULL
thymocytes	NULL
resembles	NULL
antigen-activated	NULL
mature	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
;	NULL
1139-1149	NULL
.	NULL

